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ABSTRACT 
Background: Quality of patient care may be assessed through rational use of 
medicine indicators initially developed in collaboration with WHO. These 
assessments have been carried out in primary level government clinics and hospital 
settings across the world, however, very little information is available on the 
assessment of the quality of patient care in community pharmacies, particularly in 
LMIC countries like Ghana, despite the fact that community pharmacies are an 
integral part of the health system.  
 
Aim: This study investigated the quality of care of patients or caregivers who 
presented prescriptions at community pharmacies in the Volta region of Ghana. 
 
Methods: A prospective cross-sectional study of dispensing practices at community 
pharmacies was carried out and included: analysing prescriptions presented, 
interviewing patients and observing pharmacies for availability of key medicines and 
the essential medicines list. Eighteen out of 34 registered community pharmacies in 
the region were selected using proportionate multistage random sampling. Data was 
collected from all patients presenting prescriptions during a 6-hour period at each 
selected pharmacy using adapted versions of WHO validated tools. After data 
checking and cleaning, frequencies and means were calculated and presented for the 
indicators. A composite quality of care measure was calculated for each community 
pharmacy based on optimal indices of indicators. Measures of associations were 
measured with Chi-square and p-values set at 0.05% significance. Ethical clearance 
(BM/16/5/29) was obtained from UWC BMREC and permission obtained from 
community pharmacy owners, while consent was obtained from all pharmacy staff 
and respondents prior to involvement in study. 
 
Results: A total of 318 patients or caregivers were included. The average number of 
medicines per prescription was 1.6 (range 1-6), 75% of medicines prescribed were 
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written in generic names (range 62%-100%), 65% were from the EML, and 20% and 
10% of patients were prescribed antibiotics and injections respectively. The average 
dispensing time was 184 seconds (range 20-699), 75% of medicines prescribed were 
dispensed, and 85% (range 64%-100%) of patients recalled the correct dosage of all 
medicines received while no dispensed medicine was adequately labelled. Sixty-
seven percent of community pharmacies had copies of EML/local formulary. The 
mean availability of key medicines was 97% (range 80%-100%) with 12 community 
pharmacies having all key medicines. The mean composite quality of care score for 
the community pharmacies was 8.58/11. 
 
Conclusions: Prescribing indicators were generally good whilst most patient care 
indicators were not within WHO reference values. Availability of key medicines was 
good but EML/local formulary were not consistently available. Quality of care across 
all community pharmacies was average. 
 
Recommendations: Pharmacy Council should ensure pharmacists at community 
pharmacies take up their legal responsibilities; training and monitoring should be 
introduced to improve dispensing practices of pharmacists and other support workers, 
including labelling and information provision to patients; and the government should 
encourage community pharmacies to enrol as health insurance service providers.   
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GLOSSARY 
TERM DEFINITION/MEANING 
Adverse Drug 
Reactions 
An unintended and sometimes harmful or uncomfortable reaction to 
a medicine taken at normal or usual doses. 
 
Brand Name or 
Trade Name  
 
Name given by manufacturer of a medicine and used to market the 
product. Example Tylenol is a brand name and 
Paracetamol/acetaminophen is the generic name or the INN 
 
Compounding 
Medicines 
 
Preparation or manufacture of medicines. 
 
Essential Medicines 
List 
 
A list of essential or important medicines, normally for a country. 
 
Extemporaneous 
Preparation 
 
Medicines prepared specifically for a patient upon prescription by a 
pharmacist when a pre-manufactured product is not available.  
 
Inefficacious 
Medicines 
 
Ineffective Medicines  
 
INN (International 
Non-proprietary 
name) or Generic 
name 
 
An internationally accepted name given to an active pharmaceutical 
ingredient. For example Paracetamol or Acetaminophen  
Polypharmacy A situation where medicines in excess of an acceptable number are 
prescribed for a patient 
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CHAPTER 1: INTRODUCTION 
1.0 Background 
Community pharmacies are institutions owned privately that may either be a chain of 
corporate pharmacies, or pharmacies in supermarkets or standalone/independent 
pharmacies that provide pharmaceutical services to the community (Saini & Rai, 
2012). 
Community pharmacies have been identified as “easily accessible” to society (Aslam, 
Bushra & Khan, 2012: 298). Activities carried out by community pharmacies are led 
by a community pharmacist, and these include supply of medicines to patients based 
on prescriptions, extemporaneous preparation of pharmaceutical products, treatment 
of simple ailments, provision of information to the general public as well as other 
health professionals and monitoring of patient medicine use (WHO, 1994). They also 
provide other public health services such as counselling (on lifestyle modification, on 
medicine and non-medicine treatments) and management of simple ailments 
(Porteous, Ryan, Bond, Watson & Watson, 2016).  
 
In the United Kingdom, community pharmacy services have expanded to include 
“diagnostic testing and smoke-cessation programmes” (Schafheutle, Samuels & 
Hassel, 2008: 57). The expanded role of community pharmacies or community 
pharmacists includes a concept called pharmaceutical care. Pharmaceutical care is 
simply defined as “the responsible provision of medicine therapy for the purpose of 
achieving definite outcomes which improve a patient’s quality of life” (Hepler & 
Strand, 1990: 539). Examples of pharmaceutical care include actions aimed at 
identifying, solving or reducing medicines-related problems of patients (Hepler & 
Strand, 1990).  
 
Community pharmacies have been said to be at the very heart of health care delivery 
in a population by virtue of accessibility. In Scotland, it has been estimated that 
http://etd.uwc.ac.za/
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people use the services of community pharmacies on a daily basis and that about 94% 
of the population utilize the services of community pharmacies at least once in a year 
(Eades, Ferguson & O' Carroll, 2011). The importance of community pharmacies to 
the health system globally, and in developing countries such as Ghana, thus cannot be 
over emphasized although detailed information from these settings is scanty.  
 
In addition to the community pharmacist, various categories of personnel, known as 
support staff work, in community pharmacies and utilize various levels of skills to 
perform different activities within the community pharmacy (Mullen, 2004). These 
staff work under the supervision of the pharmacist to support the delivery of 
pharmaceutical services from community pharmacies (Latif, Boardman & Pollock, 
2013). In community pharmacies in the UK setting, three categories of support staff, 
pharmacy technicians (PT), dispensing assistants (DA) and medicine counter 
assistants were identified in studies by Schafheutle et al. (2008) and Latif et al. 
(2013). In Ghana, support staff are largely pharmacy technicians, medicine counter 
assistants and people trained on the job.  
 
The use of medicines in developing countries, including Ghana, have largely been 
described as “irrational” with the intake or consumption of substandard, inefficacious, 
unwholesome medicines being a major issue (Smith, 2004: 234). A wide range of 
reasons have been attributed to the irrational use of medicines in these countries 
including inadequate numbers of qualified personnel, the prevalence of counterfeit 
products, challenges in regulatory enforcements, high cost of medicines, as well as 
cultural beliefs about medicines and their use (Smith, 2004). 
 
To investigate the use of medicines, or patterns of medicines use, the World Health 
Organisation (WHO) and the International Network for Rational Use of Drugs 
(INRUD) developed a set of indicators (WHO, 1993). These indicators cover three 
main areas; prescribing indicators (pharmaceutical prescribing practices by health 
providers), patient care indicators (from clinical consultation to medicine dispensing) 
http://etd.uwc.ac.za/
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and facility indicators (indicators which show elements of the facility which support 
rational use of medicine) (WHO, 1993). Numerous studies have employed the use of 
these indicators to describe and assess medicine pattern use in health facilities. One 
recent study by Bilal, Osman & Mulugeta (2016) in health centre settings in Ethiopia 
assessed these indicators and found prescribing and dispensing practices in surveyed 
health centres to be fairly close to the WHO standards although improvements were 
needed. Another healthcare facility setting study in Brazil by Santos & Nitrini (2004) 
found that care to patients was below standard and recommended further research into 
reasons why indicator measures were below standards. Few studies on the use of 
patient care indicators to assess quality of care or rational use of medicines have been 
conducted in community pharmacies in Ghana making it worthy of investigation. 
This study builds on other studies conducted in Africa. Previous studies as already 
mentioned have largely been conducted in health facility settings. This study, in the 
Ghanaian setting, adds to the scanty data on practices in community pharmacies. 
1.1 Study Setting 
The study setting was the Volta Region in the eastern part of Ghana. The region has 
unique features such as being geographically the longest of all regions and possessing 
all the ecological zones of Ghana (Ghana Statisical Service (GSS), 2013). According 
to 2010 Population and Housing Census Report, the region had a population of 
2,118,252 persons (GSS, 2013) and is divided into 25 districts. At the end of 2014 the 
region had 446 health institutions comprising of hospitals, clinics, health centres and 
maternity homes; ownership of these facilities is largely by the government, with a 
few privately owned and mission (religious organisation) owned facilities (Ghana 
Health Service (GHS), 2014). Pharmacies and dispensaries are included in these 
facilities, with staffing levels and the type of medications available dependent on the 
category of the facility. 
 
Community pharmacies exist in 13 out of 25 districts of the region. Data obtained 
from the regulator of pharmacies, the Pharmacy Council of Ghana, revealed that 38 
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community pharmacies exist in the region. In October 2016, out of the 38, 6 had 
suspended operation leaving 32 community pharmacies currently operating in the 
region. These pharmacies are owned by corporate bodies of which shareholders may 
be pharmacists or non-pharmacists, however, according to Part 4 (Pharmacy Council) 
of Health Professions Regulatory Bodies Act, “the business of mixing, compounding, 
preparing or supplying restricted medicines by retail must be carried out under the 
supervision of a superintendent pharmacist” or else the licence to operate may be 
revoked (Parliament of Ghana, 2013: 43).  
 
Patients who present prescriptions at community pharmacies fall into three categories: 
insurance accredited patients who opt to fill prescriptions at accredited community 
pharmacies from choice; insurance accredited patients who opt to fill prescriptions at 
community pharmacies due to stock outs in hospitals; and un-insured patients who 
buy medicines out of pocket from community pharmacies. In practice, most 
prescriptions are filled by hospital pharmacies (where the prescriptions are issued) 
resulting in relatively small numbers being presented at community pharmacies. 
1.2 Problem Statement  
Assessments of the quality of care with regards to pharmacies are skewed towards 
public sector (government) institutions. These include studies in Ethiopia by Bilal et 
al. (2016) and by Santos & Nitrini (2004) in Brazil which focussed on quality of care 
of patients presenting prescriptions at health facilities. In Indonesia, a study 
conducted by Abdulah, Barliana, Pradipta, Halimah, Diantini & Lestari (2014) 
focusing on community pharmacies investigated the quality of patient care in 
community pharmacy settings and found indicators to be close to recognised 
standards. In 2009, the Ministry of Health Ghana (2009) published the report of a 
survey of health facilities; the survey looked at aspects of WHO patient care 
indicators (adequate labelling and knowledge of dosage) in public and private 
dispensaries. Private dispensaries were not limited to community pharmacies but 
included over-the-counter medicine sellers. The survey, thus, did not provide a clear 
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picture of the quality of patient care pertaining to community pharmacies in Ghana, 
important providers within the health system.  
1.3 Purpose  
The purpose of this study is to assess the quality of care received by patients 
presenting prescriptions at community pharmacies. It is hoped that this information 
will provide a good picture of the current situation and that it could be used to 
motivate for improved quality of pharmaceutical care in these settings. 
1.4 Aim  
To describe the quality of care of patients presenting prescriptions at community 
pharmacies in the Volta Region of Ghana. 
1.5 Objectives  
The objectives of the study are: 
1) To describe patterns of antibiotic, injections and generic medicines prescribing of 
prescriptions presented at community pharmacies 
2) To describe dispensing encounters of patients presenting prescriptions at 
community pharmacies  
3) To describe compliance of community pharmacies to the essential medicines 
concept. 
4) To measure associations between elements of quality of care and exposures in 
community pharmacies. 
http://etd.uwc.ac.za/
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CHAPTER 2: LITERATURE REVIEW 
2.0 Introduction 
The study focused on quality of care of patients presenting prescriptions at 
community pharmacies and this review includes the concept of quality of care, 
rational medicine use, rational medicine use indicators and how they have been 
applied in various pharmaceutical settings. 
2.1 Quality of Care 
Quality of care has been defined as the “degree to which health services for 
individuals and populations increase the likelihood of desired health outcomes and 
are consistent with current professional knowledge”(Mitchell, 2008: 1-1). By this 
definition, quality of care can be assessed by use of quality indicators (Mitchell, 
2008). Medications, which are one of the major beneficial interventions used in a 
health system, are also associated with causing harm (Winslade, Taylor, Shi, 
Schuwirth, Van de Vleuten & Tamblyn, 2011). It is therefore imperative that the 
quality of care patients receive when medicines are supplied is assessed regularly to 
improve patient safety. Quality of patient care when receiving medicines can be 
assessed by means of rational use of medicine indicators. These quality indicators, 
developed by WHO, measure medicine pattern use in health facilities (WHO, 1993). 
These indicators are used to describe medicine usage in any health facility 
irrespective of location and are also considered to be objective ways of measuring 
(Ofori-Asenso, Brhlikova & Pollock, 2016). Several different categories of indicators 
to measure quality of care have been developed. These include: Patient care 
indicators, prescribing indicators and facility specific indicators (WHO, 1993).  
2.2 The Concept of Rational Use of Medicines 
For rational use of medicines to prevail, it requires that “patients receive medicines 
appropriate to their clinical needs, in doses that meet their own individual 
requirements, for an adequate period of time, and at the lowest cost to them and the 
http://etd.uwc.ac.za/
7 
 
community” (WHO, 1985: 299). This definition was promulgated at the WHO 
conference of experts on the rational use of medicines in Nairobi, Kenya in the year 
1985. For rational use of medicine to work, the conference of WHO (1985) also 
iterated some responsibilities for governments, health training institutions, 
manufacturing companies, regulators, prescribers, dispensers and consumers. 
2.2.1 Governments  
Governments have the responsibility to develop and implement national drug 
policies. The drug policy should address, essential medicines, an appropriate 
medicine supply system, quality control measures, monitoring of adverse drug 
reactions, human resource requirements, and inter-sectoral collaboration and 
monitoring and evaluation of procedures. 
2.2.2 Prescribers 
Prescribers should use available objective information to choose medicines. 
Prescribers should be aware of medicine prices, adverse effects of medicines, handing 
of medicine adverse effects, when medicines are not needed and skills to advice 
patients to understand when they need no medicines. 
2.2.3 Health Training Institutions 
Health training institutions should train health workers in the concepts of rational use 
of medicines. It is also recommended that training should include in-service for health 
workers already in practice. 
2.2.4 Manufacturing Companies and Regulators 
Regulators should ensure that manufacturers provide complete information about 
licensed medicines. This is important so that prescribers will have detailed, reliable 
information on pharmaceutical products they prescribe. 
http://etd.uwc.ac.za/
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2.2.5 Dispensers and Consumers 
It is the responsibility of pharmacists to dispense the correct medicines as well as 
provide the patients information on how to use the medicines correctly. They should 
also be able to identify and report adverse drug reactions that patients experience; this 
extends to other health professionals as well. Patients have the responsibility to know 
about the medicines they are taking; they should know why they are taking the 
medicines, their effects, and also follow guidelines given them by dispensers on ways 
to identify and report any adverse drug reactions that may occur. 
2.3 Irrational Use of Medicines 
Irrational use of medicines occur when there is non-compliance to the WHO 
definition of rational use of medicines (World Health Organisation, 2002). Irrational 
medicine use occurs in all countries, hospitals, pharmacies and homes (MSH 
(Management Sciences for Health), 2012). Various forms in which irrational use of 
medicines occur includes, polypharmacy, incorrect use of medicines, use of 
medicines when they are not needed, use of unsafe medicines and prescribing without 
conforming to recommendations of clinical guidelines (MSH (Management Sciences 
for Health), 2012; World Health Organisation, 2002). 
2.4 Measuring Rational Use of Medicines 
Irrational medicine use is particularly a problem in developing countries, this is as a 
result of challenges faced, and results in loss of life, morbidity, poor quality of 
medication therapy and “wastage of resources” (Afriyie & Tetteh, 2014: 142). 
Reducing irrational medicine use would have obvious benefits to patients and to the 
population as a whole. Several countries have made efforts to improve rational 
medicine use by the implementation of drug policies; these actions that aim ultimately 
at improving quality of care must also be evaluated (Walker, Hogerzeil, Sallami, 
Alwan, Fernando & Kassem, 1990). 
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The WHO and the International network for the rational use of drugs (INRUD) have 
developed indicators for measuring rational use of medicines in health care facilities 
(World Health Organisation, 2002). These indicators, as mentioned earlier include 
prescribing indicators, patient care indicators and facility specific indicators. Various 
studies have worked on the use of these indicators in health facilities, and these will 
be discussed in the next sections. 
2.5 Prescribing Indicators 
Inappropriate prescribing of medicines is a problem globally (Hogerzeil, 1995). 
Inappropriate prescribing practices of prescribers often time leads to patients 
engaging in practices such as self-medication (Chandelkar & Rataboli, 2014). 
Prescribing indicators measure quality of care at health care facilities in areas of 
rational medicine use and these indicators are, the average number of medicines per 
encounter/prescription (polypharmacy), percentage of medicines prescribed by 
generic name, percentage of encounters with antibiotics and injections prescribed and 
the percentage of medicines prescribed from an essential medicines list (EML) or 
formulary (WHO, 1993). Prescribing encounters can be measured retrospectively 
(using historical patient records) and also prospectively by observing patients who 
visit a health care facility (WHO, 1993). Prescribing indicators provide a general 
description of prescribing habits of prescribers and do not collect nor require data on 
patient signs and symptoms (Ofori-Asenso et al., 2016). 
 
Various researchers have measured prescribing indicators in health care facilities. A 
retrospective study of the prescribing patterns at  Primary Healthcare Centres 
(PHCCs) in Egypt found all prescribing indicators with the exception of average 
medicines per encounter and prescriptions with injections to be below optimal levels 
(Akl, Mahalli, Elkahky & Salem, 2014). The study also found that results for 
prescriptions with antibiotics were generally above the reference values (Akl et al., 
2014). A second study of prescribing indicators in Ghana, which was also done using 
retrospective data focused on prescribing patterns in public and privately owned 
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PHCCs; the study found that antibiotic prescribing was generally higher than 
previous national averages (Ahiabu, Tersbol, Biritwum, Bygbjerg & Magnussen, 
2016). A third study by Afriyie & Tetteh (2014) described the pattern of rational drug 
use in a hospital in Ghana and used retrospective data to measure prescribing 
indicators. The study found that generally rational medicine use in the hospital was 
not at a satisfactory level. 
 
It must be noted that none of these studies involved community pharmacies. Another 
study conducted in Ethiopia by Srikanth, Tesfaye, Degife, Ergetie, Muhammed & 
Atinafu (2013) involved the use of prescriptions from community pharmacists as well 
as from public health facilities in Ethiopia. The study concluded that prescribers 
adhered to the use of medicines recommended by the Ethiopian national medicines 
list (Srikanth et al., 2013).  
Other studies have also described prescribing patterns based on prescriptions 
available at health care facilities such as hospitals, clinics, however it appears few 
have studied the pattern at community pharmacies, the thrust of this research. 
 
One of such few is a study at rural community pharmacies in India where it was 
found that medicines were largely not prescribed by their generic names and also the 
need for improvement in the availability of essential medicines and essential 
medicine guidelines (Aravamuthan, Arputhavanan, Subramaniam & Udaya Chander 
J, 2017). Another study in private community pharmacies in Nepal found prescribing 
practices to be below standards (Chapagain, Pokharel & Paranjape, 2016).  
2.6 Patient Care Indicators 
Patient care indicators also assess important components of the service patients 
receive when they visit health institutions (WHO, 1993). The indicators are: average 
consultation time (patient with prescriber),  average dispensing time, percentage of 
medicines actually dispensed and percentage of medicines actually labelled (El 
Mahalli et al., 2012 ; Akl et al., 2014). Shorter dispensing times may indicate poor 
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services. In a study of health centres in Ethiopia, the average consultation time was 
5.7 minutes, dispensing time was 2.7 minutes, 64.0% of medicines received were 
adequately labelled and 69% of patients had adequate knowledge about medicines 
(Bilal et al., 2016). This showed that with the exception of dispensing time all other 
indicators fell short of the optimal. In Namibia, a study conducted in public hospitals 
in all 14 regions of the country, found the mean percentage of medicines dispensed to 
be 77.7%, 59.3% of medicines dispensed were adequately labelled and more than 
80% of patients not knowing how to take medicines prescribed for them (Kibuule, 
Lates, Kagoya, Bayobuya, Niaz & Rennie, 2017).  
 
Another African based study conducted in primary and tertiary hospitals in Ethiopia 
by Gidebo, Summoro, Kanche & Woticha (2016) found patient care indicators; 
dispensing time, the number of medicines prescribed, percentage of medicines 
labelled and dispensed, to be below reference standards.  In Saudi Arabia, a study of 
primary health care centres (PHCC), found the average consultation time was 7.3 
minutes, dispensing time was 99.6 seconds, 10 % of medicines adequately labelled 
and 79.3% of patients had adequate knowledge about medicines dosage (El Mahalli et 
al., 2012). It must be noted that patient care indicators are measured using prospective 
data (WHO, 1993). Another study of prescribing and dispensing practices in a 
hospital in Ethiopia , found that the percentage of medicines adequately labelled was 
11% and this was described as being poor (Sisay, Abdela, Kano, Araya, Chemdi & 
Fiseha, 2017). 
 
Very few studies have been carried out in community pharmacy settings, but a recent 
study in Indonesia found the average dispensing time to be 62 seconds, 99% of 
medications were adequately labelled, 96% of prescribed medicines were dispensed 
and 88% of patients knew the correct dosage of medicines received (Abdulah et al., 
2014). The findings fairly indicated a relatively high quality of all indicators. Another 
study at community pharmacies in India measured the average consultation times, 
dispensing times and percentage of medicines prescribed (Aravamuthan et al., 2017). 
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In Serbia a study compared medicine use (patient care) indicators between private and 
state owned community pharmacies and found no significant differences between the 
two settings (Prokic, Davidovic & Gunjic, 2014).  
2.7 Facility Specific Indicators  
Facility indicators devised by WHO measure two quality indicators which are the 
availability of essential medicines in facilities and the availability of an Essential 
Medicines List in the facility (WHO, 1993). These indicators are important because 
the availability of medicines and information about medicines can influence the 
quality of service patients receive in health facilities.  
 
Various studies have also measured these indicators in health care institutions. A 
study of Primary Health Care Clinics in Saudi Arabia found 90% of facilities having 
EMLs and 59.2% of key medicines in stock (El Mahalli et al., 2012). Another study 
of PHCCs in Egypt also found that generally the percentage availability of key 
medicines and EML or local formularies was lower the optimum level required (Akl 
et al., 2014). Bilal et al. (2016) measured health facility indicators in health centres in 
Ethiopia and found that 6 out of 8 health centres surveyed had a copy of the Ethiopian 
EML. Gidebo et al. (2016) also conducted a health facility study in Ethiopia and 
found availability of EML to be 25% and availability of key medicines to be 65.7%. 
None of these studies were conducted in community pharmacy settings. 
2.8 Reference/Standard Values for Indicators 
Measuring indicators without comparison to standard values make it difficult to 
determine the performance of an indicator in a particular setting. The current group of 
indicators were “finalized” following various field testing in African countries, 
Nigeria and Tanzania (WHO, 1993: 5). This led to the compilation of the manual, 
“How to investigate drug use in health facilities”. However, the manual did not 
clearly define reference values for the indicators. In 2006, the WHO book on using 
indicators to measure country pharmaceutical situations reiterated this point, that 
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prescribing indicators such as the mean number of medicines per prescription, 
percentage of encounters with antibiotics and injections prescribed did not have 
specified reference values but did suggest minimum thresholds for them (Appendix 
1). The WHO (2006), however, noted that reference values for indicators may vary 
from country as they are influenced by country specific treatment guidelines, patterns 
of disease and country specific medicine policies. Reference values for indicators 
such as availability of key medicines, percentage of medicines dispensed, adequacy 
of labelling and compliance with treatment guidelines are expected to have an optimal 
values of 100% (WHO, 2006). 
 
Prior to the WHO (2006) a group of researchers, Isah et al. (2002), developed a set of 
optimal values for prescribing indicators (Appendix 1). The development was based 
on morbidity profiles and medicine treatment guidelines for prevalent diseases in 
Nigeria (Isah et al., 2002). The reference values for average number of medicines 
prescribed, antibiotic and injections prescriptions were not too different from the 
WHO (2006) manual. Subsequently, various studies including those by Bilal et al. 
(2016) and Desalegn (2013), compared prescribing indicators to the reference values 
developed by Isah et al. (2002). A recent study by Sisay et al. (2017) used a 
combination of WHO (2006) and Isah et al. (2002) reference values in their study. 
The reference value for the average dispensing time varied between publications, 
some publications used ≥60 seconds (Akl et al., 2014; El Mahalli et al., 2012), whilst 
others used >180 seconds (Bilal et al., 2016).  
 
The concept of optimal index of RUM indicators has been used in quite a number of 
studies. This concept compares the optimal level of an indicator to 1. The closer to 1, 
the more rational the indicator (Dong, Yang & Wang, 2011). The optimal index was 
based the use of a mathematical model developed by Zhang and Zhi for appraisal of 
healthcare, a method that had been validated and used in various health research 
settings (Zhang & Zhi in Dong et al., 2011)  
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CHAPTER 3: RESEARCH DESIGN AND METHODOLOGY 
3.1 Study Design 
The study employed was a cross-sectional analytical design and the WHO 
standardized methodology, tools and indicators were adapted for use in this study 
(WHO, 1993). A cross sectional design was deemed appropriate because the study 
investigated an area in which there was little information available, that was, patient 
care in community pharmacies in Volta region of Ghana. Participants were surveyed 
at one point in time removing the possibility of loss to follow up which could bias the 
study (Sedgwick, 2014). The analytical nature of this design also offered the 
opportunity to measure association between variables. In addition, a cross sectional 
design was also suitable for this study because of the relative ease to perform and 
cheap costs (Sedgwick, 2014). 
3.2 Study Population 
The study population was all 34 active community pharmacies in Volta Region. The 
study population increased from 32 to 34 because two community pharmacies who 
had suspended operations reopened during the protocol development period. 
Patient/caregiver encounters were drawn from patients/caregivers presenting 
prescriptions at community pharmacies. It was estimated that an average of 30 
patients per-day present prescriptions at each community pharmacy (personal 
information). All patients/caregivers presenting prescriptions were eligible for the 
study.  
3.3 Study Sampling  
All 34 active community pharmacies in 13 districts served as the primary sampling 
unit.  Distribution of pharmacies per district was as follows: Ho-11, Hohoe-5, Ketu 
South-4, North Tongu-3, Kpando-2, Nkwanta South-2 and seven other districts had 
one pharmacy in each. A multistage sampling process was used to select community 
pharmacies using both proportional and random sampling techniques. In all 18 
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community pharmacies were selected. A tabular description of sampling is shown in 
Appendix 2. For a period of 6 hours, all patients who presented prescriptions at 
selected community pharmacies and who provided informed consent were included in 
the study. 
3.4 Data Collection  
Data was collected using adapted versions of standardized tools developed by the 
WHO (1993). Prior to commencement of data collection, two pilot studies were 
conducted in two community pharmacies (not included in the study) in the Ho district 
prior and minor changes were made to the data collection tools. The tools and 
definitions used are attached in Appendix 3-5.  
 
Tool 1: Prescribing Indicator Form collected data on the sex, age and gender of 
patients presenting prescriptions, the number of medicines, number of generic 
medicines prescribed, presence of antibiotic and injections on prescriptions and 
number of essential medicines list medicines prescribed (Objective 1). The gender of 
the patient was included following the pilot study to offer more demographic 
information on the patient. 
 
Tool 2: Patient/Caregiver Form collected the following data from each 
patient/caregiver: the dispensing time, the number of medicines prescribed, the 
number of medicines adequately labelled, the presence of a pharmacist during 
dispensing, the patients’ knowledge of correct dosage after dispensing and the 
category of person who actually dispensed. The latter was added after the pilot study 
to further describe what categories of personnel dispense to patients/caregivers. The 
tool also included a questionnaire component that collected data on demographics of 
respondents and reasons behind their visits to the community pharmacies. (Objective 
2). Modifications were made to the questionnaire after the pilot study because, it will 
help describe and explore reasons patients/caregivers choose to use community 
pharmacy services. 
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Tool 3: Community Pharmacy Summary Form measured the availability of a 
current national medicines list and formulary in pharmacies and the availability of 
key medicines in pharmacies (Objective 3). Following the pilot study, the tool was 
modified to include the age of community pharmacy, Health insurance accreditation 
status of community pharmacy as well as other types of formularies available at the 
community pharmacy. These modifications were made to further describe the 
community pharmacies 
 
Data collection was be carried out by the principal investigator (a licenced 
pharmacist) and one other trained data collector who was an intern pharmacist. Data 
collection commenced on 31st January 2017 and ended on 31st May 2017. On the day 
of data collection the data collectors visited the community pharmacy before 10 am 
and collected data using Tool 3. At 10am data collection using Tools 1 and 2 
commenced and continued for a period of six hours. The second data collector 
(pharmacist intern) was stationed at the waiting area of the community pharmacy 
while the principal investigator who was a pharmacist, was stationed behind the 
counter but not in immediate contact with workers. 
 
Patients/caregivers who visited the community pharmacy with prescriptions were 
initially approached by second data collector and informed about the study using the 
Participant Information Sheet (Appendix 6-9), and if they agreed to participate they 
were requested to sign the Consent Form (Appendix 10-12). Patients/caregivers then 
visited the counter and data on Tool 2 (dispensing time, number of medicines 
prescribed, category of dispenser and presence of pharmacist) were captured. After 
the patient/caregiver left the counter, the questionnaire component of the Tool 2 and 
the number of medicines dispensed and adequately labelled were captured. The 
principal investigator collector reviewed the prescription after the patient had been 
served to capture data on Tool 1. 
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3.5 Data Management and Analysis 
All data forms were checked for accuracy and completeness before leaving the 
community pharmacy. Data collected were entered onto an excel spreadsheet twice to 
ensure accuracy of entries and after data cleaning the averages and percentages were 
calculated using excel. For the purposes of data analysis, patients were grouped into 
two age groups, adults and children. Adulthood starts at 18 years according to 
Ghanaian Law; persons below 18 years are considered to be children (Parliament of 
Ghana, 1998). Criteria for measuring and calculating dispensing time, defining 
patients’ adequacy of knowledge of dosage, defining adequacy of medicine labelling,  
antibiotics, injections and determination of key medicines, are specified in Appendix 
3-5. The name of a medicine on a prescription was determined to be a generic name 
when the International Nonproprietary Name (INN) was written on the prescription. 
Reference values for WHO standardised indicators as well as optimal indices were 
used to calculate total quality measures.  
3.5.1 Reference Values for WHO Standardized Indicators & Optimal Levels 
There are no real “internationally accepted empirically determined valid standards” 
for optimal levels of prescribing indicators such as mean number of medicines per 
prescription, percentage of patients prescribed antibiotics and injections; however, 
prescribing from EML and availability of key medicines are required to be a 100% 
(WHO, 2006 :4). The reference values from various studies and a WHO manual are 
available in Appendix 1 for comparison. 
 
The reference values for determining the optimal levels for all indicators in the 
protocol of this research were based on two published articles Akl et al. (2014) and El 
Mahalli et al. (2012), studies conducted in PHCCs in Egypt and Saudi Arabia 
respectively. However, the WHO (2006), fact book on using indicators to measure 
country specific pharmaceutical situations proposed a range for prescribing indicators 
and these were also similar to derived values for prescribing indicators obtained in a 
study by Isah et al., (2002) and in a systematic review of prescribing indicators in 
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both public and private settings in Africa by Ofori-Asenso et al. (2016). Prescribing 
indicator levels were thus modified to what the WHO (2006) manual. The patient care 
indicators and facility specific indicators remained the same as in the protocol. The 
optimal level indicators are presented in Table 1 below. The only variations from 
original proposal are the average number of medicines per prescription (≤3 now <2) 
and the percentage of patients prescribed with injections (≤10 now <20). 
 
Formulae for calculation of indicators are available in Appendix 3-5. Indicators were 
computed for each community pharmacy and also for the entire group of community 
pharmacies. Indicator results for the entire group was calculated based on pooling all 
individual patients results and the computing the indicator results. This was the 
method used in Dong et al. (2011) and Bilal et al. (2016).  
3.5.2 Optimal Index and Quality of Care Measure 
Calculation of the optimal indices were based on methods used in Akl et al., (2014) 
and Dong et al. (2011). The optimal index for the average number of medicines 
prescribed, percentage of prescriptions/encounters with antibiotics or injections were 
obtained by dividing the optimal indices in the case of percentage of prescriptions 
with antibiotics (<30) by the percentage of prescriptions with antibiotics obtained; the 
same applied to percentage of prescriptions with injections. Calculation of the index 
for the average dispensing time was obtained by dividing the average dispensing time 
obtained by the optimal level (≥60 seconds). For all other indicators whose optimal 
value was 100%, the optimal index was calculated by dividing the results obtained by 
the optimal level (100). Optimal index for all indicators is a maximum of 1 even 
when the calculated answer is greater than 1. An indicator with an optimal index of 1 
implies a medicine is being  used rationally (Akl et al., 2014).  
 
A quality of care measure was developed to compare community pharmacies. A 
composite quality of care measure for each community pharmacy was calculated 
based on optimal indices of indicators. Out of a maximum cumulative optimal index 
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of 11: 0-4 = poor quality of care; 5-8 = average quality of care; 9-11= good quality of 
care (See Table 1). 
 
 
Table 1: Optimal Level and Optimal Index of Indicators used as a Measure of 
Quality of Care 
No 
 
Indicator Optimal Level Optimal 
Index 
 
 Prescribing Indicators 
 
   
1 Average Number of medicines per 
encounter/prescription 
<2 1  
2 Percentage of medicines prescribed by 
generic name 
100% 1  
3 Percentage of encounters with antibiotics <30% 1  
4 Percentage of encounters with injections 
prescribed 
<20% 1  
5 Percentage of medicines prescribed from 
essential medicines list 
100% 1  
 Cumulative Index for Prescribing 
Indicators 
  
 
 
5 
     
 Patient Care Indicators 
 
   
6 Average dispensing time 
 
≥ 60seconds 1  
7 Percentage of medicines actually 
dispensed 
 
100% 1  
8 Percentage of medicines actually labelled 
 
100% 1  
9 Patients knowledge of correct dose 
 
100% 1  
 Cumulative Index for Patient Care 
Indicators 
  
 
            
4 
     
 Facility Indicators 
 
   
10 Availability of essential medicines list or 
national formulary 
100% 1  
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11 Percentage Availability of key medicines 
 
100% 1  
 Cumulative Index for Facility 
Indicators 
   
2 
 Total Quality of Care Measures 
 
  11 
 
Epi-info7 was up-loaded with data entered from excel and bivariate analysis was used 
to measure associations between exposures such as the category of personnel 
dispensing and indicator measure such as patient’s knowledge of correct dosage. 
Measures of associations were measured with Chi-square tests and significance levels 
set at 0.05. 
3.6 Validity and Reliability 
In research “validity determines whether the research truly measures that which it was 
intended to measure or how truthful the research results are” (Joppe, 2000 in 
Golafshani, 2003 : 599). To improve validity through reduction of selection bias, 
participants were interviewed in three major languages in the region, English, Ewe or 
Twi (Akan). Data collectors ensured that dispensers did not know indicators being 
measured, in order for them not to decide to impress the researcher by deliberately 
putting up the best practice; the study attempted as much as possible to measure the 
real everyday situation. Recall bias was limited because participants were required to 
recall dispensing encounters immediately after they occurred. 
 
Reliability refers to the repeatability of the a study finding or the consistency of the 
study measurements over a time period (Golafshani, 2003). To increase reliability 
experienced data collectors, who were also pharmacists, and WHO standardised tools 
which have been pretested in other settings was employed. Since timing of dispensing 
was measured, the same digital clock was used in all pharmacies and the periods for 
starting and stopping timing was specified; this was similar across all participants and 
settings. Prior to commencing the study the data collection tools were pre-tested for 
ambiguity and clarity in two community pharmacies in the Ho district which were not 
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part of selected pharmacies. Necessary modifications were made to tools as described 
under Data collection.  
 
3.7 Limitations  
This cross sectional study was liable to non-response bias as some of the selected 
participants declined to participate in the study. This study being a cross-sectional 
study was also be unable to infer causation between exposures and outcomes. The 
survey was also subject to response bias as some participants may have responded to 
questions inaccurately or may have chosen to answer the question in a way that 
sounds socially correct. An example was caregivers who answered the question of 
whether the person they were taking care of was a subscriber to a health insurance 
scheme.  
 
Although participants were asked to recall their encounters immediately after being 
served in the pharmacy, there was still a possibility of recall bias; participants may 
have forgotten what they were told and rather recalled a past or wrong dosage which 
could lead to an information bias. The study being quantitative investigated what 
happened quantitatively but was unable to investigate in-depth the reasons behind the 
observations found. Participant bias was minimised because pharmacy staff were not 
aware of the exact indicators measured. Observer bias was reduced because data 
collectors were well trained on tools, definition of indicators and the use of standard 
data collection procedures at all facilities. The 6-hour data collection period (10am to 
4pm) was determined from the pilot study as the period which most prescriptions 
were presented at community pharmacies, however, there could still be some groups 
of patients/caregivers who visit the pharmacies before 10am or after 4pm.  The study 
missed such persons and could have suffered from selection bias.   
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3.8 Ethics Considerations 
Ethical approval for the study with reference number BM/16/5/29, was given by the 
University of the Western Cape Biomedical Research Ethics Committee (BMREC) 
(Appendix 13). Prior to commencement of the study, permission (Appendix 14) was 
obtained from owners or managers of Community Pharmacies. After receiving 
permission, participant information sheets were given to key pharmacy staff and a 
signed consent was taken before data collection commenced. A participant 
information sheet was given to or read to patients/care givers in any of the 3 
languages of participant’s choice (English, Ewe and (Akan) Twi) (Appendix 6-9). An 
informed consent was taken before research was conducted (Appendix 10-12).  
 
Participation was voluntary; participants were free to participate and free to leave at 
any time. The research ensured that participants’ rights or respect for human dignity 
were held in high esteem. Confidentiality of the participant was also assured. The 
study was governed by the principle of non-maleficence ; researchers ensured that the 
respondents were not harmed in any way as a result of the study (Wassenaar, 2006). 
Questions were not asked in a manner that traumatized or intimidated participants. 
Although arrangements were made for the handling of traumatic experiences no 
participant reported a case of being traumatized during the survey. Participants were 
identified by codes and data collected was kept in a locked cupboard and password 
protected computer, accessible only to the principal investigator. 
 
Findings of the study will be disseminated to stakeholders in pharmacy practice 
including managers of community pharmacies in the Volta region, the Pharmaceutical 
Society of Ghana, the Pharmacy Council and the Chief Pharmacist of the Ministry of 
Health. 
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CHAPTER 4: RESULTS 
4.1 Introduction 
The study described the quality of care of patients presenting prescriptions at 
community pharmacies in the Volta region of Ghana using tools which captured 
information on prescribing practices, patient care and the community pharmacy 
facility. A total of 318 (69%) out of 463 patients/caregivers consented and were 
observed and interviewed across 18 selected community pharmacies (CPs) during the 
one-day (6 hour) study period which took place between 31st January 2017 and 31st 
May 2017. The total number of patients/caregivers who sought services at the CPs 
during the same study time period without using prescriptions was 1349; they were 
not part of the study as the focus was on those presenting prescriptions. 
4.2 Demographics of Patients and Caregivers 
The demographics of patients and caregivers are shown in Table 2. Out of the 318 
prescriptions presented at the CPs, 66% (209) were for female patients while 34% 
(109) were for male patients. With the exception of CPs 3, 4, 9, and 18, all other 
community pharmacies received more prescriptions for female patients than for male 
patients. Eighty-one percent (259) patients were adults, while the rest were children 
(<18years). The age range was one day to 94 years; the mean age was 39 years. 
Patients who were below 18 years were all represented by caregivers.  Of the 318 
patients, 88% (280) were insured. Forty-eight percent (154) had their prescriptions 
presented by caregiver who were mostly male, 84 (54.5%), and their age range was 
18 to 65 years with the mean age being 37 years. Most patients, (86%), reported that 
the reason for presenting prescriptions at CPs was because hospitals were out of stock 
of medicines prescribed; the remainder, (14%), reported a combination of reasons 
including long queues at hospital pharmacies, preferring the services of CPs and 
medicines being out of the scope of health insurance hence not stocked by the 
hospital.  
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Table 2: Demographics of Patients and Caregivers presenting Prescriptions 
CP District Patients (n=318) Caregivers (n=154) 
Gender Age group (yrs.) Insured Gender Age (yrs.) 
  Male 
f (%) 
Female 
f (%) 
Adult 
> 18 
f (%) 
Child 
<18 
f (%) 
Mean 
Age  
(Range) 
Patients  
f (%) 
Male 
f (%) 
Female 
f (%) 
Mean Age  
(Range) 
1 Jasikan 5 (38%) 8 (62%) 13 (100%) 0 41(19-83) 12 (92%) 5 (63)% 3(38%) 42 (27-59) 
2  Ho 10 (33%) 20 (67%) 28 (93%) 2 (7%) 34 (2-64) 28 (93%) 8 (73%) 3 (23%) 35(23-58) 
3 Ho 4 (67%) 2 (33%) 3 (50%) 3 (50%) 29 (4-55) 6 (100%) 0 3 (100%) 39 (32-45) 
4 Ho 6 (50%) 6 (50%) 10 (83%) 2 (17%) 28 (0.02-
68) 
10 (83%) 5 (83%) 1 (17%) 35 (25-48) 
5 Ho 7 (33%) 14 (67%) 17 (81%) 4 (19%) 42 (0.75-
85) 
20 (95%) 8 (62%) 5 (38%) 33 (18-43) 
6 Ho 6 (37.5%) 10 
(62.5%) 
12 (75%) 4 (25%) 33 (0.6-70) 10 
(62.5%) 
7 (70%) 3 (30%) 33 (19-65) 
7 Ho 10 (31%) 22 (69%) 24 (75%) 8 (25%) 37 (0.003-
80) 
26 (81%) 10 (53%) 9 (47%) 40 (18-63) 
8 Ketu South 9 (29%) 22 (71%) 26 (84%) 5 (16%) 40 (1-80) 26 (84%) 6 (46%) 7 (54%) 38 (20-62) 
9 North Tongu 4 (57%) 3 (43%) 6 (86%) 1 (14%) 48 (5-76) 5 (71%) 2 (40%) 3 (60%) 40 (22-55) 
10 Hohoe 4 (36%) 7 (64%) 8 (73%) 3 (27%) 42 (0.9-75) 10 (91%) 2 (29%) 5 (71%) 30 (18-45) 
11 Kpando 7 (21%) 27 (79%) 23 (68%) 11 (32%) 40 (0.01-
83) 
33 (97%) 6 (32%) 13 (68%) 35 (24-55) 
12 South Tongu 11 (34%) 21 (66%) 25 (78%) 7 (22%) 37 (1-94) 29 (91%) 8 (62%) 5 (38%) 39 (18-56) 
13 Hohoe 8 (32%) 17 (68%) 23 (92%) 2 (8%) 51 (6-86) 25 
(100%) 
5 (56%) 4 (44%) 42 (26-56) 
14 Hohoe 7 (44%) 9 (56%) 14 (87.5%) 2 (12.5%) 46 (3-81) 14 
(87.5%) 
3 (43%) 4 (57%) 37 (27-47) 
15 Ketu North 3 (33%) 6 (67%) 9 (100%) 0 41 (18-70) 7 (78%) 3 (60%) 2 (40%) 35 (24-49) 
16 Nkwanta South 2 (40%) 3 (60%) 5 (100%) 0 37 (23-50) 4 (80%) 4 (100%) 0 30 (27-33) 
17 Kadjebi 0 6 (100%) 5 (83%) 1 (17%) 41 (10-83) 6 (100%) 1 (100%) 0 18 
18 Ketu South 6 (50%) 6 (50%) 8 (67%) 4 (33%) 36 (1-68) 9 (75%) 1 (100%) 0 45 
Total 109 
(34%) 
209 
(66%) 
259 
(81%) 
59 
(19%) 
39 
(0.003-94) 
280 
(88%) 
84 
(54.5%) 
70 
(45.5%) 
37 
(18-65) 
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4.3 Prescribing Patterns on Prescriptions Presented at Community 
Pharmacies 
Prescribing indicator results as depicted in Table 3 show that overall the average 
number of medicines prescribed per prescription presented was 1.6 with a range of 1-
6 medicines. CP 18 at Ketu South had the lowest average, 1.2 medicines per 
prescription whilst, two CPs 6 and 14, both recorded the highest, 2.1 medicines. Only 
one pharmacy, CP 16, recorded 100% of medicines prescribed by generic name. With 
the exception of CPs 2 and 9, all CPs recorded the percentage of patients/encounters 
prescribed antibiotics below 30%. Prescriptions with injections were 60% in CP 16 
and 22% in CP 15, these were the highest (beyond optimal of 20); CPs 9, 13 and 14 
recorded no injection prescriptions. None of the CPs recorded the optimal level of 
100% for the percentage of medicines prescribed from the EML. CP 13 reported the 
least at 46% whilst CP 16 reported the highest at 86%. 
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Table 3: Prescribing Patterns on Prescriptions presented at Community 
Pharmacies 
 
 
 
CP 
No 
 
 
 
Distri
ct 
Prescribing Indicators 
Average 
medicines 
/prescripti
on 
 
 
Reference 
Standard: 
<2 
Percentage 
generics/prescr
iption 
 
 
 
Reference 
Standard: 
100 
Percentag
e patients 
prescribed 
antibiotics 
 
 
Reference 
Standard: 
<30 
Percentage 
patients 
prescribed 
injections 
 
 
Reference 
Standard: 
<20 
Percentage 
medicines 
prescribed 
from EML 
 
 
Reference 
Standard: 
100 
1 Jasika
n 
1.6(1-4) 90 15 15 67 
2 Ho 1.7 (1-5) 68 33 13 58 
3 Ho 1.3 (1-2) 88 17 17 75 
4 Ho 1.4 (1-2) 71 8 8 53 
5 Ho 1.3 (1-2) 71 29 5 64 
6 Ho 2.1(1-6) 65 25 6 59 
7 Ho 1.7(1-4) 78 25 19 69 
8 Ketu 
South 
1.3 (1-3) 68 19 16 66 
9 North 
Tongu 
1.4 (1-3) 80 43 0 60 
10 Hoho
e 
1.4 (1-3) 80 27 0 67 
11 Kpan
do 
1.8 (1-5) 84 21 15 81 
12 South 
Tongu 
1.2 (1-2) 81 13 0 68 
13 Hoho
e 
1.6 (1-3) 62 4 0 46 
14 Hoho
e 
2.1 (1-5) 74 25 0 71 
15 Ketu 
North 
1.4 (1-3) 69 0 22 54 
16 Nkwa
nta 
South 
1.4 (1-2) 100 0 60 86 
17 Kadje
bi 
1.5 (1-3) 89 17 0 78 
18 Ketu 
South 
1.2 (1-2) 79 17 8 64 
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Total  1.6 (1-6) 75 20 10 65 
 
4.4 Dispensing Encounters of Patients Presenting Prescriptions at 
Community Pharmacies  
Table 4 describes the dispensing encounters by means of patient care indicators. The 
reference value for dispensing time was ≥60 seconds and all CPs recorded average 
dispensing times greater than the optimal value. CP 17 recorded the lowest average 
dispensing time of 102 seconds whilst CP 9 recorded the highest average dispensing 
time of 292 seconds. Only CP 9 recorded a 100% (optimal value) for the percentage 
of medicines dispensed. Further questioning revealed that medicines were not 
dispensed in 27% of cases; 42% due to medicines being out of stock at the CP, 28% 
due to the medicines being unaffordable to the patient, 19% because they had already 
received the medicines from hospital and 11% were a combination of these reasons. 
All CPs scored 0% for adequacy of labelling. In CPs 3, 9, 16 and 17 all 
patients/caregivers who received medicines were able to recall the correct dosage of 
medicines they received from the dispensers. CP 1 recorded the lowest, 64% for 
percentage of patients/caregivers with correct knowledge of dosage.  
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Table 4: Dispensing Encounters of Patients Presenting Prescriptions at 
Community Pharmacies   
 
 
 
 
CP 
No 
 
 
 
 
District 
Patient Care Indicators 
Average 
dispensing 
time (secs) 
 
 
Reference 
Standard: 
≥60 
Percentage  
medicines 
dispensed 
 
 
Reference 
Standard: 
100 
Percentage 
medicines 
adequately 
labelled 
 
Reference 
Standard: 
100 
Percentage of 
patients/caregivers 
with correct 
knowledge of dosage 
 
Reference 
Standard: 
100 
1 Jasikan 273 (98-610) 52 0 64 
2 Ho 184 (30-415) 70 0 78 
3 Ho 102 (62-190) 63 0 100 
4 Ho 183 (34-512) 71 0 70 
5 Ho 141 (20-308) 82 0 94 
6 Ho 143 (36-381) 44 0 88 
7 Ho 201 (57-537) 85 0 75 
8 Ketu South 247 (53-627) 85 0 86 
9 North 
Tongu 
292 (116-600) 100 0 100 
10 Hohoe 137 (48-254) 60 0 88 
11 Kpando 224 (53-530) 77 0 93 
12 South 
Tongu 
115 (31-321) 89 0 87 
13 Hohoe 144 (39-336) 77 0 90 
14 Hohoe 261 (33-699) 82 0 92 
15 Ketu North 136 (29-277) 69 0 71 
16 Nkwanta 
South 
208 (47-359) 71 0 100 
17 Kadjebi 102 (62-190) 44 0 100 
18 Ketu South 143 (30-278) 86 0 70 
Tota
l 
 184 (20-699) 75 0 85 
 
4.5 Compliance of Community Pharmacies to the Essential Medicines 
Concept    
Table 5 shows how CPs complied with the essential medicines concept and indicates 
that 67% (12 out of 18) of CPs had a copy of the Ghana Essential Medicines List 
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(EML) or the Standard Treatment Guidelines (local formulary). These facilities thus 
scored 100% for the indicator percentage availability of copy of EML or local 
formulary. The availability of key medicines (see Appendix 5 for list) were also 
measured and the mean percentage availability for all CPs combined was 97% with a 
range of 80-100. A total of 12 CPs scored 100% for availability of key medicines.  
4.6 Characteristics of Community Pharmacies 
Further CP characteristics are shown in Table 5. Seventeen percentage of CPs were 
accredited to health insurance schemes; mean operational year (age) of CPs surveyed 
was 11 (range 6 months to 33 years); mean proximity of CPs to the nearest health 
facilities (where it was assumed most prescriptions would have originated) was 800m 
(range 100m to 1.6km); 56% of health facilities in closest proximity to CPs were 
government owned, 22% were privately owned and 22% were owned by mission 
organisations. 
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Table 5: Community Pharmacy Characteristics 
 
 
 
CP  
No 
District Essential 
Medicines 
List / Local 
Formulary 
Available 
Percentage 
Availability 
of Copy of 
EML or 
Local 
Formulary 
 
Reference 
Standard: 
100 
Percentage 
Availability 
of Key 
Medicines 
 
 
 
Reference 
Standard: 
100 
Accredite
d to 
Health 
Insurance 
Scheme 
Operationa
l Years of 
Community 
Pharmacy 
Distance 
to 
health 
facility 
(km) 
Owner
-ship 
of 
neares
t 
health 
facility  
1  Jasikan Yes 100 93 No 0.5 0.7 Govt 
2 Ho No 0 100 No 8 0.1 Govt 
3 Ho No 0 100 Yes 5 0.8 Private 
4 Ho Yes 100 93 Yes 9 1 Govt 
5 Ho Yes 100 100 No 19 1.3 Private 
6 Ho Yes 100 93 No 12 1 Private 
7 Ho Yes 100 100 Yes 17 0.65 Private 
8 Ketu 
South 
No 
0 
100 No 20 0.3 Govt 
9 North 
Tongu 
Yes 
100 
100 No 0.5 0.15 
Missio
n 
10 Hohoe Yes 100 93 No 21 0.6 Govt 
11 Kpando 
No 
0 
100 No 10 0.65 
Missio
n 
12 South 
Tongu 
Yes 
100 
100 No 13 1.6 Govt 
13 Hohoe No 0 100 No 33 0.15 Govt 
14 Hohoe No 0 100 No 4 1 Govt 
15 Ketu 
North 
Yes 
100 
100 No 4 1.12 
Missio
n 
16 Nkwanta 
South 
Yes 
100 
100 No 7 1.6 
Missio
n 
17 Kadjebi Yes 100 87 No 11 0.5 Govt 
18 Ketu 
South 
Yes 
100 
80 No 0.7 1.3 Govt 
Summary 12 (67%) Mean: 67 
Mean: 97 
(80-100) 
3 
(17%) 
Mean: 11 
(0.5-33) 
Mean:0.
8 (0.1-
1.6) 
Gov: 
56%, 
Miss: 
22% 
Private
: 22% 
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4.7 Characteristics of Pharmacists and Dispensers at Community 
Pharmacies 
Table 6 shows characteristics of pharmacists and dispensers at CPs. Pharmacists were 
present at CPs at the time when 53% (170) of the encounters took place. Seventy-
seven percentage (245) prescriptions were dispensed by MCAs, whilst pharmacists 
dispensed 9% (30) of the time. Three other groups of support staff were present at the 
CPs, they were pharmacy technicians (PT), physician assistants (PAs) and senior high 
school (SHS) graduates who have been trained on the job. A PA was the only 
dispenser in CP 17 whilst SHS dispensers were at CP 7.  
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Table 6: Characteristics of Pharmacists and Dispensers at Community 
Pharmacies 
CP 
No 
District Pharmacis
t Present 
 
Category of dispenser  
   Pharmacis
t 
MCA PT SHS PA 
1 Jasikan 10 (77%) 10 (77%) 3 (23%) 0 0 0 
2 Ho 19 (63%) 3 (10%) 27 (90%) 0 0 0 
3 Ho 3 (50%) 0 4(67%) 2 (33%) 0 0 
4 Ho 0 0 12 (100%) 0 0 0 
5 Ho 0 0 8 (38%) 13(62%) 0 0 
6 Ho 0 0 16 (100%) 0 0 0 
7 Ho 30 (94%) 0 15 (47%) 0 17 
(53%) 
0 
8 Ketu South 15 (48%) 2(6%) 24 (77%) 5 (16%) 0 0 
9 North 
Tongu 
2 (29%) 0 7 (100%) 0 0 0 
10 Hohoe 8 (73%) 0 11 (100%) 0 0 0 
11 Kpando 0 0 34 (100%)    
12 South 
Tongu 
32 (100%) 4 (12.5%) 28 
(87.5%) 
0 0 0 
13 Hohoe 25 (100%) 0 25 (100%) 0 0 0 
14 Hohoe 0  16(100%) 0 0 0 
15 Ketu North 9 (100%) 3(33%) 6 (67%) 0 0 0 
16 Nkwanta 
South 
5 (100%) 5(100%) 0 0 0 0 
17 Kadjebi 0 0 0 0 0 6 
(100%) 
18 Ketu South 12 (100%) 3 (25%) 9 (75%) 0 0 0 
Total 
 
170 (53%) 30 (9%) 245 (77%) 20 (6%) 17 (5%) 6 (2%) 
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4.8 Quality of Care at Community Pharmacies 
4.8.1 Introduction 
The quality of care received by patients at CPs was measured using a scale that 
graded the cumulative optimal indices of CPs. This section shows the optimal indices 
calculated based on a total of 11 indicator measures for each CP: prescribing – five 
indicators (Table 7), patient care – four indicators (Table 8) and facility specific – two 
indicators (Table 9).  
4.8.2 Prescribing Index 
Table 7 shows that for the index of non-polypharmacy all CPs, with the exception of 
CPs 6 and 14, achieved the optimal value of 1. Only CP 16 achieved the optimal 
value of 1 for the index of generic prescribing. CPs 2 and 9 were the only facilities 
whose optimal index for antibiotic prescribing was below 1. No CP achieved the 
optimal value of 1 for the index of EML prescribing. The total achievable optimal 
prescribing index was 5 and all CPs scored a total prescribing index above 4, with the 
highest being 4.67 attained by CP 17 and the least being 4.04 attained by CP 14. The 
overall prescribing index for all CPs was 4.40.  
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Table 7: Prescribing Indexes at Community Pharmacies 
  Prescribing Indexes  
C
P 
No 
District Index of 
Non- Poly-
pharmacy 
 
 
Optimal 
Index: 
1 
 Index of 
Generic 
name 
prescribing 
 
Optimal 
Index: 
1 
Index of 
Antibiotic 
prescribing 
 
 
Optimal 
Index: 
1 
Index of 
Injection 
prescribing 
 
 
Optimal 
Index: 
1 
Index of 
EML 
prescribing 
 
 
Optimal 
Index: 
1 
Total 
 
 
 
 
Optimal 
Index: 
5 
1 Jasikan 1 0.90 1 1 0.67 4.57 
2 Ho 1 0.68 0.91 1 0.58 4.17 
3 Ho 1 0.88 1 1 0.75 4.63 
4 Ho 1 0.71 1 1 0.53 4.24 
5 Ho 1 0.71 1 1 0.64 4.35 
6 Ho 0.95 0.65 1 1 0.59 4.19 
7 Ho 1 0.78 1 1 0.69 4.47 
8 Ketu 
South 
1 0.68 1 
1 
0.66 4.34 
9 North 
Tongu 
1 0.80 0.70 
1 
0.6 4.1 
10 Hohoe 1 0.80 1 1 0.67 4.47 
11 Kpando 1 0.84 1 1 0.81 4.65 
12 South 
Tongu 
1 0.81 1 
1 
0.68 4.49 
13 Hohoe 1 0.62 1 1 0.46 4.08 
14 Hohoe 0.95 0.74 1 1 0.71 4.4 
15 Ketu 
North 
1 0.69 1 
0.91 
0.54 4.14 
16 Nkwant
a South 
1 1 1 
0.33 
0.86 4.19 
17 Kadjebi 1 0.89 1 1 0.78 4.67 
18 Ketu 
South 
1 0.79  
1 
1 
0.64 4.43 
Total   
1 
 
0.75 
 
1 
 
1 
 
0.65 
 
4.4 
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Table 8: Patient Care Indexes at Community Pharmacies 
  Patient Care Indexes  
CP 
No 
District Index of 
Dispensi
ng time 
 
Optimal 
Index: 
1 
Index of 
Medicines 
dispensed 
 
Optimal 
Index: 
1 
Index of 
Medicine 
labelling 
 
Optimal 
Index: 
1 
Index of 
patients 
knowledge of 
dosage 
Optimal 
Index: 
1 
Total 
 
 
 
Optimal 
Index: 
4 
1 Jasikan 1 0.52 0 0.64 2.16 
2 Ho 1 0.7 0 0.78 2.48 
3 Ho 1 0.63 0 1 2.63 
4 Ho 1 0.71 0 0.7 2.41 
5 Ho 1 0.82 0 0.94 2.76 
6 Ho 1 0.44 0 0.88 2.32 
7 Ho 1 0.85 0 0.75 2.6 
8 Ketu South 1 0.85 0 0.86 2.71 
9 North Tongu 1 1 0 1 3 
10 Hohoe 1 0.6 0 0.88 2.48 
11 Kpando 1 0.77 0 0.93 2.7 
12 South Tongu 1 0.89 0 0.87 2.76 
13 Hohoe 1 0.77 0 0.9 2.67 
14 Hohoe 1 0.82 0 0.92 2.74 
15 Ketu North 1 0.69 0 0.71 2.4 
16 Nkwanta 
South 
1 0.71 0 1 2.71 
17 Kadjebi 1 0.44 0 1 2.44 
18 Ketu South 1 0.86 0 0.7 2.56 
Total 1 0.75 0 0.85 2.60 
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4.8.2 Patient Care Index 
Table 8 shows that all CPs achieved the optimal level for the index of dispensing 
time. No facility achieved the optimal level for index of adequate medicine labelling, 
while only CP 9 achieved the optimal mark for the index of medicines dispensed. All 
patients were able to recall the correct dosage of medicines dispensed in CPs 3, 9, 16 
and 17, this resulted in an optimal value of 1. The total patient care index achievable 
by all CPs was 4. The highest total index, 3 was attained by CP 9. The lowest was 
2.16, attained by CP 1. The overall patient care index obtained by all CPs was 2.60. 
4.8.2 Facility Specific Index 
Table 9 shows the optimal index measure for facility specific indicators. Six CPs, 2, 
3, 8, 11, 13 and 14 scored 0 for the availability of an EML/local formulary implying 
none was available. All CPs with the exception of CPs 2, 4, 6, 10, 17 and 18 scored 
the optimal index for availability of key medicines. The total facility specific index 
attainable was 2. Six of the CPs attained the maximum index of 2, while six CPs, 2, 3, 
8, 11, 13 and 14 scored the least value, 1. The overall facility specific index obtained 
by all CPs was 1.64.  
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Table 9: Facility Specific Indexes at Community Pharmacies 
  Facility Specific Indexes  
CP 
No 
District Index of Availability 
of Copy of EML or 
Local Formulary 
 
Optimal Index: 
1 
Index Of 
Availability of Key 
Medicines 
 
 
Optimal Index: 
1 
Total 
 
 
 
Optimal Index: 
2 
 
1 Jasikan 1 0.93 1.93 
2 Ho 0 1 1 
3 Ho 0 1 1 
4 Ho 1 0.93 1.93 
5 Ho 1 1 2 
6 Ho 1 0.93 1.93 
7 Ho 1 1 2 
8 Ketu South 0 1 1 
9 North Tongu 1 1 2 
10 Hohoe 1 0.93 1.93 
11 Kpando 0 1 1 
12 South Tongu 1 1 2 
13 Hohoe 0 1 1 
14 Hohoe 0 1 1 
15 Ketu North 1 1 2 
16 Nkwanta South 1 1 2 
17 Kadjebi 1 0.87 1.87 
18 Ketu South 1 0.80 1.80 
 Total 0.67 0.97 1.64 
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4.8.3 Quality Index 
The quality index displayed in table 10 is based on summation of optimal values for 
each community pharmacy and shows that based on the proposed rating, four CPs - 5, 
7, 9 and 12 achieved the good quality of care measure whilst the rest achieved 
average. 
Table 10: Quality Index for Community Pharmacies 
Facility 
No 
District Prescribing 
Indicators 
 
 
Max: 5 
Patient 
Care 
Indicators 
 
Max: 4 
Facility 
Specific 
Indicators 
 
Max: 2 
Total 
 
 
 
Max: 11 
Quality 
Measure 
 
 
Rating 
1 Jasikan 4.57 2.16 1.93 8.66 Average 
2 Ho 4.17 2.48 1 7.65 Average 
3 Ho 4.63 2.63 1 8.26 Average 
4 Ho 4.24 2.41 1.93 8.58 Average 
5 Ho 4.35 2.76 2 9.11 Good 
6 Ho 4.19 2.32 1.93 8.44 Average 
7 Ho 4.47 2.6 2 9.07 Good 
8 Ketu 
South 
4.34 2.71 1 8.05 Average 
9 North 
Tongu 
4.1 3 2 9.1 Good 
10 Hohoe 4.47 2.48 1.93 8.88 Average 
11 Kpando 4.65 2.7 1 8.35 Average 
12 South 
Tongu 
4.49 2.76 2 9.25 Good 
13 Hohoe 4.08 2.67 1 7.75 Average 
14 Hohoe 4.4 2.74 1 8.14 Average 
15 Ketu 
North 
4.14 2.4 2 8.54 Average 
16 Nkwanta 
South 
4.19 2.71 2 8.9 Average 
17 Kadjebi 4.67 2.44 1.87 8.98 Average 
18 Ketu 
South 
4.43 2.56 1.80 8.79 Average 
Mean 4.37 2.59 1.63 8.58 Average 
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4.9 Measures of Association 
Associations between some elements of that contribute to the quality of care were 
measured using chi-square test of association and are shown in Table 11.  Dispensing 
by pharmacist was analysed against dispensing time >60 seconds and patients 
knowledge and neither were significant at the 0.05 level. 
Table 11: Associations between Dispensing by Pharmacist and Patient Care 
Indicators 
Patient Care Indicators 
Prescriptions 
dispensed by 
pharmacist   
f (%) 
Prescription 
not dispensed 
by pharmacist         
f (%) 
 
Chi-
square 
p-Value 
Dispensing 
time 
>60sec 
Yes 29/292 (10%) 263/292 (90%)  
1.0348 0.3098 
No 1/26 (4%) 25/26 (96%) 
Patients 
knowledge   
Good 19/227 (8%) 208/227 (92%)  
1.6111 0.2043 
Poor 6/41 (15%) 35/41 (85%) 
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CHAPTER 5: DISCUSSION 
5.1 Introduction 
This section discusses the study results obtained. It commences with the socio-
demographics of patients and caregivers presenting prescriptions and the 
characteristics of community pharmacies and dispensers. Subsequent sections discuss 
the indicators measured, quality of care and measures of associations. It should be 
noted that as little information is available on prescribing practices and quality of care 
at community pharmacy (CP) settings in Africa and other Low and Middle Income 
Countries (LMICs) comparisons were made with PHCC settings in these countries 
and CPs in other countries. 
 
During the 6-hour study period a total of 318 prescriptions were presented at the 18 
study CPs and of these 66% were for females and 34% for males. This was similar to 
a recent study in rural CPs in India, where females comprised 57.5% and males were 
42.5% (Aravamuthan et al., 2017). The larger female to male populations at CPs 
implies that females are more concerned about their health than their male 
counterparts and this is in line with general findings on health seeking behaviours 
(Wathoni & Rahayu, 2014). The age grouping was similar to a study in Australia 
where it was found that most patients, (80.8%), who submitted prescriptions at CPs 
were adults (> 20 years). In this study, one reason for this could be that infants and 
children are more likely to receive care at the government facilities (Wathoni & 
Rahayu, 2014). Some patients were represented at CPs by caregivers; all caregivers 
were adults (18-65years), mostly male and with a mean age of 37 years. Perhaps 
surprisingly more caregivers were male than female, but this could be due to several 
factors including mobility and cultural norms which could be explored in further 
studies. Health insurance has become an important component of the Ghanaian health 
sector financing structure in recent years and the results showed that 88% of the 
patients were insured. This was consistent with a study in public and private PHCCs 
in Ghana by Ahiabu et al. (2016) where 90.3% of patients were insured. 
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The CPs surveyed were largely facilities that have been in operation for a 
considerable number of years (mean 11 years) suggesting they have sufficient 
experience to provide CP services to clients. A large number of them were close to 
health facilities, implying that patients who do not receive pharmaceutical services at 
hospitals for one reason or the other can easily access CPs for pharmaceutical 
services. For most CPs the nearest health facility was government owned and, as the 
majority of patients in Ghana utilise government health facilities, the CPs were 
suitably located. 
 
In Ghana, as in most countries, CPs operate under the supervision of registered 
pharmacists (Parliament of Ghana, 2013). In this study pharmacists were present at 
CPs 53% of the time which was higher than a previous study in Ghana where 
pharmacists were present at private facilities 34.3% of the time (MOH Ghana, 2009). 
The absence of the pharmacist is against the law and it betrays the public as 
confidence in CP services are generally high (MOH Ghana, 2009). It is also expected 
that pharmacists will be the last person patients with prescriptions speak to when 
leaving the CP. The results of the study (Table 5) indicated that only 9% of patients 
received their medications from pharmacists which was even lower than a study in 
Ghana which reported 19.1% of dispensers being pharmacists (MOH Ghana, 2009). 
This is concerning as pharmacists are usually considered to have responsibility to 
ensure that patients are given the requisite knowledge about the medicines prescribed 
for them. This is supported by several studies which have shown that the quality of 
the patient-pharmacist interaction has an impact on medicine compliance (Garjani et 
al., 2009 in Abdulah et al., 2014). 
 
The majority of support staff present at CPs were medicine counter assistants (MCAs) 
and this was consistent with a report from the UK (Mullen, 2004). It was also 
worrying to find that most patient client interactions (dispensing) were carried out by 
MCAs (77%) (Table 6). This is because the role of MCAs as defined the Ghanaian 
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Pharmacy Council does not include dispensing of prescriptions to patients, indeed 
their closest role when it comes to patient/dispenser medicines interactions is selling 
over-the–counter (OTC) medicines under the supervision of a pharmacist (Pharmacy 
Council, 2010). 
5.2 Prescribing Patterns of Prescriptions Presented at Community 
Pharmacies 
The mean number of medicines per prescription was 1.6 (range 1-6) (Table 3), which 
was within reference value of <2 (WHO, 2006) and implied that there was not 
polypharmacy which tends to be associated with an increased risk of adverse drug 
reactions (Alomar, 2014). Two studies at public health facilities in Ghana reported 
higher results (3.7 and 4) (MOH Ghana, 2009; Afriyie & Tetteh, 2014). Studies at 
health facilities in other African countries also reported higher results; a study at 
PHCCs in Egypt (2.5),  a health centre study in Ethiopia (2.2) and a study at various 
categories of hospitals in southern Ethiopia (2.0) (Akl et al., 2014; Bilal et al., 2016; 
Gidebo et al., 2016).  Studies conducted in CP settings in two LMICs were also 
higher; a study conducted at CPs in India (3.7) and a study conducted at CPs in Nepal 
(2.14) (Aravamuthan et al., 2017; Chapagain et al., 2016). This study surveyed 
prescriptions from hospitals presented at CPs. Although the results suggested that on 
average CPs in the Volta region do not receive polypharmacy prescriptions, the 
reason may be that patients received some medicines already directly from the 
hospital and thus only presented prescriptions for what they do not receive at CPs. 
 
The percentage of generic prescribing of 75% (Table 3), was below the optimal value 
of 100%. A study conducted at PHCCs in Egypt recorded higher results (95.4%), 
(Akl et al., 2014). The study results was higher than that of a study at public health 
facilities in Ghana, commissioned by the Ministry of health (59.9%) (MOH, 2009). In 
CP settings in LMICs in Asia, lower percentages were recorded; a study conducted in 
India (2.5%) and in a study conducted in Nepal (45.18%) (Aravamuthan et al., 2017; 
Chapagain et al., 2016). The results suggested that prescriptions presented at CPs in 
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the Volta Region were often not according to generic names and thus irrational in this 
regard. The WHO prefers prescribing by use of INN or generic names because it 
allows easy identification of medicines which supports prescribing, dispensing, and 
communication amongst health professional (WHO, 2017a). This unsatisfactory 
generic prescribing could be ascribed to a number of reasons. Some prescribers may 
still prefer the use of brand names because of their familiarity with some brands, 
others may lack trust in the quality of generic products or lack knowledge about 
availability of generic versions of some branded products (Steinman, Chren & 
Landefeld, 2007). Some authors have suggested that prescribing by brand names 
should not be encouraged as it may lead to adverse drug reactions especially in 
instances where patients are unknowingly prescribed different brands of the same 
medicines because prescribers were not aware that patients current medication was 
the same as brand being prescribed (Steinman et al., 2007).  
 
The results obtained for the percentage of patients prescribed antibiotics, 20%, (Table 
3) was below the above the optimal value of < 30 suggesting rational antibiotic 
prescribing. Irrational antibiotic use is associated with increasing antibiotic resistance, 
a global problem, and may cause mortality and morbidity (WHO, 2006). The study 
result was lower than other studies in CP settings in LMICs in Asia and at health 
facility settings in Ghana and other African countries; a study at CPs in India (22%), a 
study at CPs in Nepal (40.44%), PHCCs in Egypt (39.2%) and Ghana (43.3%), and 
health centres (82.5%) in Ethiopia (Aravamuthan et al., 2017; Chapagain et al., 2016; 
Akl et al., 2014; Ahiabu et al., 2016; Bilal et al., 2016). However, the result was 
higher than that of a study at the Police Hospital in Ghana that recorded a low 11.9% 
for antibiotic prescribing (Afriyie & Tetteh, 2014). Although the study results 
suggested rational antibiotic prescribing which is a positive sign, it is important to 
note that some patients may have been given antibiotics at the hospital prior to 
presenting prescriptions at the CP. 
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Overall the results from 18 CPs indicated that percentage of prescriptions with 
injections (10%) was within the reference value of <20 suggesting rational injection 
prescribing. The study results was lower than those of studies at health facilities in 
Ghana and other African countries; a study at public health facilities in Ghana 
(13.3%), a study at public and private PHCCs in Ghana (24.2%) and a study at health 
centres in Ethiopia (11.2%) (MOH Ghana, 2009; Ahiabu et al., 2016; Bilal et al., 
2016).  The results was however higher than those of studies at CPs in LMICs in Asia 
and PHCCs in an African country; a study at CPs in Nepal (3.44%), a study at CPs in 
India (7.2%) and a study at PHCCs in Egypt (9.9%) (Chapagain et al., 2016; 
Aravamuthan et al., 2017; Akl et al., 2014). In general, prescriptions containing 
injections have been found to be high in lower income countries with some health 
workers respond to patient requests for injections even when they are not needed 
(WHO, 2006; MSH (Management Sciences for Health), 2012). In addition, the 
unnecessary use of injections is associated with increased risks of infections such as 
HIV, Hepatitis B and other diseases (WHO, 2006; MSH (Management Sciences for 
Health), 2012). However, although the rational injection prescribing is a positive sign, 
it must again be noted that patients who presented prescriptions may have received 
injections at hospitals prior to visiting the CPs. 
 
The results showed that 65% of the medicines prescribed were listed in the Ghana 
EML. This was below the optimal reference value of a 100%. The result was lower 
than that of a study at public health facilities in Ghana (87.5%), a study at health 
centres in Ethiopia (92%) and a study at PHCCs in Egypt (95.4) (MOH Ghana, 2009; 
Bilal et al., 2016; Akl et al., 2014). The results was also lower than two studies 
conducted at CPs in Asian LMICs; Nepal (76.11%) and India (99.8%) (Chapagain et 
al., 2016; Aravamuthan et al., 2017). The result was marginally lower than results of 
a study at village health clinics in Western China (67.7%) (Dong et al., 2011). The 
comparisons above suggested that various settings in Ghana and other countries 
outperformed the results obtained in the study. The reasons for prescribing of non-
EML listed medicines in the Volta region could be that prescribers preferred non-
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EML medicines or also because patients required medicines which were not listed in 
the EML which hospital did not stock, hence prescriptions sent out to CPs.  
 
5.3 Dispensing Encounters of Patients Presenting Prescriptions at 
Community Pharmacies 
The results from the study (Table 4) showed that the average dispensing time of 184 
seconds was above the optimum value of ≥60 seconds. The time spent during 
dispensing is considered very important for optimum patient care and is critical 
because errors in dispensing takes a toll on the quality of care received (James et al, 
2009 in Abdulah et al., 2014). Patients non-adherence to medications may also be due 
to inadequate provision of medicine information which can be as a result of 
inadequate dispensing time, however it must be noted that other factors such as 
patients beliefs, poor labelling of medicines and financial challenges also can 
influence non-adherence (Le Grand, Hogerzeil & Haaijer-Ruskamp, 1999). The 
results was higher than those of studies at CP settings in an Asian LMIC and an 
eastern European upper middle income country; a study in Indonesia (62 seconds) 
and a study in Serbia (state owned-15.58 seconds, private owned-18.15seconds) 
(Abdulah et al., 2014; Prokic et al., 2014). In health facility settings in other African 
countries, mixed results were found, 47.4 seconds at PHCCs in Egypt,  127 seconds at 
health centres in Ethiopia and 119.1 seconds at various categories of hospitals in 
southern Ethiopia (Akl et al., 2014; Bilal et al., 2016; Gidebo et al., 2016).   The 
longer dispensing time in the study as compared with other studies mentioned above 
suggested that dispensers spent sufficient time on the dispensing process and with 
patients and could be inferred that patients received optimum care. However, the 
findings on labelling and patient knowledge discussed below disappointedly indicate 
poor dispensing practices. 
 
The results (Table 4) from this study reported that patients received on average 75% 
of medicines from all facilities, although some facilities recorded 100%. Patients’ 
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receipt of all medicines prescribed them ensures they have the requisite medicines for 
optimum pharmaceutical therapy. Comparing the 75% to CP settings in Asia and 
eastern Europe showed that patients in the Volta region received less medicines 
prescribed; in Indonesia (96%), in India (99.8%) and in Serbia (state owned: 92.7%, 
private owned: 91.9%) (Abdulah et al., 2014; Aravamuthan et al., 2017; Prokic et al., 
2014). Studies at health facility settings in other African countries also reported 
higher percentage of medicines dispensed. These were: 77.7% at public hospitals in 
Namibia (Kibuule et al., 2017), 86.22% at heath centres in Ethiopia (Bilal et al., 
2016), 86.3% at various categories of hospitals in Southern Ethiopia (Gidebo et al., 
2016) and 95.9% at PHCCs in Egypt (Akl et al., 2014). Key reasons attributed in this 
study were that CPs were out of stock of the medicines, patients could not afford all 
the prescribed medicines at the time of the visit or that they had already received the 
medicines from the hospital. 
 
The result for adequacy of labelling was very poor 0% compared to the reference 
standard of a 100%. The WHO definition for adequate labelling is that the label must 
contain “at least patient name, medicine name and when the medicine should be 
taken” (WHO, 1993:18). No CP scored a point for adequacy of labelling by the above 
definition. Patients who visit pharmacies should be given properly labelled medicines 
as poor labelling may lead to inappropriate medication use, medication errors and all 
the possible negative consequences. More specifically, the absence of the name could 
lead to consequences such as medicine misuse, medicine abuse and medicine 
overdose which may be potentially fatal (Jankovic et al., 1999). The results obtained 
in the study was largely because all dispensers failed to write the patients name when 
labelling the medicines. This result of 0% which was due to a lack of patients name 
on labelling was similar to results obtained at CP setting in eastern Europe (Serbia) 
(Prokic et al., 2014) and a study of PHCCs in an African country (Egypt) (Akl et al., 
2014) where the standard WHO adequate labelling definition was applied. However, 
a CP setting in an Asian LMIC (Indonesia) where the full WHO definition was also 
used reported 96% (Abdulah et al., 2014). 
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The MOH, Ghana (2009) study recorded 78% for adequate labelling in public health 
dispensaries and 62.3 % in private dispensaries, however, the definition for adequate 
labelling was not clearly stated. A study at health centres in Ethiopia reported an 
adequate labelling 60.56%; the definition used was the presence of medicine name, 
strength and duration of use (Bilal et al., 2016). A study at public hospitals in 
Namibia reported 59.3% for adequate labelling; the definition used was not elucidated 
(Kibuule et al., 2017). The lack of the patient name on the labelling material could not 
be properly explained by the quantitative study, however, a few postulated reasons 
could be work load, a lack of adequate labelling material, lack of regulatory policy on 
labelling or sufficient training. It must be noted that one CP even had labelling 
material with columns for patients name, dosage regimen and medicine name, yet the 
patients name was not written in any case. This is an important area for future 
investigation. 
 
The study results (Table 4) showed that 85% of patients recalled the correct dosage of 
all medicines received which was below the optimum value of a 100%. Provision of 
information on how medicines are to be used is a way to ensure that irrational 
medicine (sub optimal dosing, over dosing) use from the side of the patient does not 
occur. In a study by MOH, Ghana (2009) public health dispensaries scored a similar 
85% whilst private dispensaries scored 76.7%. A CP study in an Asian LMIC 
(Indonesia), reported a figure (88%) which was not too far from that obtained in the 
study (Abdulah et al., 2014). In a CP setting in eastern Europe (Serbia), a much lower 
percentage was reported; private owned dispensaries reported 56.2%, whilst state 
owned dispensaries reported 58.71% (Prokic et al., 2014). Other African country 
studies conducted at health facility settings where lower results were obtained were  a 
study at health centres in Ethiopia (69.8%) (Bilal et al., 2016) and a study at various 
categories of hospitals in southern Ethiopia (78.8%) (Gidebo et al., 2016). A study at 
PHCCs in Egypt did report a higher value (94%) (Akl et al., 2014). When patients fail 
to understand dosage regimen and instructions provided to them by the health 
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professional, the quality of health care is compromised (Martin,Williams, Haskard & 
DiMatteo, 2005). Whilst patients’ inability to recollect dosage of medicines is not 
confined to Ghana, it does never-the-less highlight another area of concern. 
5.4 Compliance of Community Pharmacies to the Essential Medicines 
Concept 
The results of the study (Table 5) showed that the availability of key medicines across 
all 18 CPs was 97% (80-100%) lower than the optimal value of 100% but still very 
good. The availability of key/essential medicines is also important because the 
inadequate supply of medicines can have a detrimental effect on the health of patients 
(Akl et al., 2014). The study results was higher than studies in health facility settings 
in Ghana and an African country; a study of public health facilities in Ghana (94.4%), 
a study at PHCCs in Egypt (78.3%) and a study at various categories of hospitals in 
Southern Ethiopia (65.7%) (MOH Ghana, 2009; Akl et al., 2014; Gidebo et al., 2016). 
The result was also higher when compared to a community pharmacy study in an 
Eastern European country, Serbia, where percentage availability of key medicines 
was 77.14% in state owned pharmacies and 80.95% in privately owned pharmacies 
(Prokic et al., 2014). The results at CPs in this setting may be higher than the health 
facilities in Africa because of possible different methods used in product sourcing.  
 
Only 67% CPs (Table 5) had copies of the Ghana EML or a local formulary and this 
was lower than the reference value of 100%. It is important for health professionals to 
have reference materials that can provide readily available local information on 
medicines. With the much promoted use of the EML across the country, it was 
expected that CPs would have copies of the EML and/or local formularies to guide 
them when making choices of essential medicine purchases. The result was lower 
than studies at public health institutions in Ghana (75%), a hospital in Ghana (77.8%) 
and PHCCs in Egypt (80%) (MOH Ghana, 2009; Afriyie & Tetteh, 2014; Akl et al., 
2014). A study at hospitals in Southern Ethiopia recorded a lower result, 25% 
(Gidebo et al., 2016). In an upper middle income country, Serbia, state owned 
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pharmacies reported 100% availability of EML, whilst private owned reported 42.8% 
(Prokic et al., 2014). Further investigation into the distribution of EML/local 
formularies to CPs in Ghana should be investigated. 
 
5.5 Quality of Care at Community Pharmacies 
Quality of care at each CP was also calculated using an aggregation of optimal 
indexes. The optimal indexes were developed through the application of a 
mathematical model developed by Zhang and Zhi previously applied in a study at 
village health clinics in China and at public and private healthcare facilities in 
Tanzania (Dong et al., 2011; Irunde et al., 2017). An optimal index of 1 for an 
indicator means that the indicator measure was rational; the farther away from 1, the 
less rational and an indication of poor performance with regards the indicator being 
measured. Aggregation of the results for each CP was used as a quality measure. In 
this section the study results are compared to other studies utilising this quality index. 
 
The overall index of non-polypharmacy was 1 which implied that CPs generally 
received non-polypharmacy prescription. As mentioned earlier this could have 
resulted from patients’ receipt of some medications at hospitals before visiting CPs 
for the remainder. This result (Table 7) was similar to that of a study at hospitals in 
Ethiopia (1.0) (Sisay et al., 2017), but was however higher than that of a study at 
public and private healthcare facilities in Tanzania (0.88) (Irunde et al., 2017) and a 
study at village health clinics in China (0.94) (Dong et al., 2011).  
 
The overall index for generic prescribing was 0.75, higher than a study at village 
health clinics in China (0.64) (Dong et al., 2011), but lower than that of a study at 
health care facilities in Tanzania (0.96) (Irunde et al., 2017) and then a study in 
Ethiopia (0.93) (Sisay et al., 2017). The <1 generic prescribing index meant that 
prescriptions presented at community pharmacies in the study region were largely 
irrational with regards the indicator. 
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Overall antibiotic prescribing index was 1 and implied less antibiotic containing 
prescriptions were presented. Other studies, in contrast, performed poorly; a study in 
China (0.62) (Dong, Yan and Wang, 2011), a study in Tanzania (0.44) (Irunde, Minzi 
and Moshiro, 2017) and a study in Ethiopia (0.59) (Sisay et al., 2017). Similarly, 
index of injection prescribing was also 1, a better result than those of other studies in 
China (0.44) (Dong, Yan and Wang, 2011), in Ethiopia (0.42) (Sisay et al., 2017) ,and 
in Tanzania (0.55) (Irunde et al., 2017). The poor result from other studies mentioned 
may also be attributed to the fact that those were conducted at health facilities where 
injections are often used as compared prescriptions sent to community pharmacies 
that maybe largely for OPD patients. 
 
The index of EML prescribing was 0.65, less than the optimal of 1. The result was 
lower than a study in Ethiopia (1.0) (Sisay et al., 2017) and a study in Tanzania (0.97) 
(Irunde et al., 2017). The results was marginally similar to that of a study in China 
(0.68) (Dong et al., 2011). 
 
The index of dispensing time was 1 (Table 8), and implied adequate dispensing time. 
This result of 1 was lower than that of a study in Ethiopia (0.33) (Sisay et al., 2017). 
Other studies calculated the optimal index for individual facilities but did not 
calculate for all. One study was that of (Akl et al., 2014) at PHCCs in Egypt, where 
the overall average dispensing time was 47.4 seconds. The derived optimal index 
based on the reference value (≥60seconds) was 0.79, lower than that of this study. 
Another of such studies where overall index for dispensing time was not calculated 
but overall measure and reference value provided was also that of (El Mahalli et al., 
2012) , at PHCCs in Saudi Arabia, where the derived optimal index for dispensing 
time was 1 based on a reported average dispensing time of 100seconds and reference 
value of ≥60seconds. 
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The index of medicines dispensed from the study (0.75) was lower than that of a 
study in Ethiopia (0.86) (Sisay et al., 2017). The study result was also lower than the 
derived Optimal index in two other studies for the same indicator; 0.996 in a study at 
PHCCs in Saudi Arabia (El Mahalli et al., 2012) and 0.96 in a study at PHCCs in 
Egypt (Akl et al., 2014). 
 
The index for adequacy of labelling was 0, reasons discussed earlier under heading 
5.3. The result obtained was similar to that of the derived optimal index in a study in 
Egypt (Akl et al,. 2014). The result was however lower than that of a study in 
Ethiopia (0.11) (Sisay et al., 2017) and the derived index for a study at PHCCs in 
Saudi Arabia (0.1) (El Mahalli et al., 2012). 
 
The index of patients knowledge was 0.85, lower than the derived index in a study at 
PHCCs in Egypt (0.94) (Akl et al,. 2014) but higher than the derived index in a study 
at PHCCs in Saudi Arabia (0.79) (El Mahalli et al., 2012). 
 
The index of availability of EML or local formulary was 0.67 (Table 9), implied non-
conformance to the EML concept. This was lower than the derived value (0.90) (El 
Mahalli et al., 2012) from a study at PHCCs in Saudi Arabia and lower that the 
derived value from a study at PHCCs in  Egypt (0.80) (Akl et al., 2014). Index of 
availability of key medicines was near optimum (0.97). This meant that community 
pharmacies surveyed performed well in this regard. This was higher than the derived 
optimal index in a study at PHCCs in Egypt (0.78) and a study of PHCCs in Saudi 
Arabia (0.59) (Akl et al., 2014; El Mahalli et al., 2012). 
 
Table 10 shows an aggregation of all indices for each facility. The aggregate indices 
are then grouped into various quality measures. The highest was good quality of care 
and the least average. The overall quality of care based on the aggregations was. A 
careful analysis of the table (10), patient care indicators were the main reason why 
http://etd.uwc.ac.za/
52 
 
most facilities scored average. This was because no facility scored a point for 
labelling.  
 
5.6 Measures of Association 
Associations between some elements that contribute to the quality of care at CPs were 
measured using chi-square tests (Table 11). The value of the chi-square test for the 
association between dispensing by a pharmacist and the patient knowledge was 1.611 
with a p value of 0.2043. The optimum dispensing time was above 60 seconds. The 
chi-square result for the association between, dispensing ≥60seconds and the 
exposure dispensing by pharmacist was 1.0348 with a p-value of 0.3290. Both 
associations were not significant at the set 0.05 level. 
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CHAPTER 6: CONCLUSIONS AND RECOMMENDATIONS 
6.1 Conclusions 
The study found that patients presenting prescriptions at community pharmacies 
(CPs) in the Volta region of Ghana during the 6-hour period were mostly female, 
adults and subscribers to health insurance schemes in Ghana; caregivers were mostly 
male. 
 
Overall prescribing indicators were good with the exception of generic prescribing 
and EML list prescribing which fell short of the WHO reference. Non-polypharmacy 
prescriptions were within range and were better than CPs in Asia and the national 
median of Ghana. Antibiotic and injection prescribing were also within range 
implying rational prescribing, however, these as well as non-polypharmacy could 
have been influenced by patients receiving some medicines at hospitals prior to 
visiting CPs. Generic prescribing was irrational, although it was better than other CPs 
in Asian LMICs and a recent study at health facilities in Ghana conducted by the 
Ministry of Health. Reasons for poor generic prescribing may include prescriber’s 
preference for branded medicines, lack of awareness of availability of generic 
versions of established brands and a mistrust of generic products. Prescribing from 
the Ghana EML was below the WHO reference and also lower than studies in CP 
settings in Asian LMICs and in health facility settings in other African countries. The 
low usage of EML listed medicines could be due to the prescribers’ preference for 
non EML listed medicines or prescribers feeling the need to use a product not listed 
in the EML.  
 
Patient care indicators were not within WHO reference with the exception of 
dispensing times.  Dispensing times were generally rational, however, the majority of 
dispensing and counselling was carried out by non-pharmacists, MCAs. Labelling of 
medicines and patient knowledge of dosages were extremely poor, although not 
unique to this setting, and the lack of pharmacist input may be a reason for these poor 
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practices. In addition, despite the legislative requirement pharmacists were not even 
present at some CPs during the study period and whilst this is a consistent trend with 
earlier studies conducted by the Ministry of Health in Ghana, it is a matter of concern 
which needs to be addressed by the regulator, the Pharmacy Council, and professional 
bodies. 
 
The percentage of medicines dispensed was below the WHO standard, and also lower 
than CP settings in Asia and Eastern Europe with reasons including stock outs, 
medicines already supplied at hospitals and patients inability to afford them. 
However, the availability of key medicines, which are drawn from the EML was 
impressive. This was an encouraging finding as many CPs did not have copies of 
EML or local formularies. 
 
The quality of care, graded using aggregation of optimal indices, showed that the 
quality of care received at CPs was between average and good. The main reason for 
the average quality care rating for most CPs was poor results obtained from labelling 
of medicines. If all CPs had better results for labelling, the quality of care would have 
increased from average to good. Finally, associations between the category of 
dispenser and the patients’ ability to recall correct dosage of all medicines, and the 
category of dispenser and optimal dispensing time were not significant at the set 0.05 
level. 
 
6.2 Recommendations 
The abstract of this study will be forwarded to policy makers such as the Pharmacy 
Council, the Ministry of Health and the Pharmaceutical Society of Ghana.  
The following recommendations in order of priority are proposed: 
1. The Pharmacy Council should improve enforcement of laws and regulations 
to ensure pharmacists take up their legal responsibilities. 
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2. Training and monitoring to improve dispensing practices of pharmacists and 
other support workers in labelling and information provision to patients. 
3. The Pharmaceutical Society should engage pharmacists and remind them of 
their duties and ethical responsibilities of providing optimum pharmaceutical 
services to the general public. 
4. Training of prescribers in EML concepts, including the use of generic names 
and prescribing from EML. 
5. The Ministry of Health should promote the use of EML and local formularies 
at CPs. The national drug program of the Ministry of Health should make free 
copies available (including e-versions) to CPs. 
6. The Pharmacy Council through periodic monitoring should ensure the 
availability of EML, local formularies and other important reference 
materials. 
7. Government should put in place policies and measures to encourage CPs to 
enrol into the health insurance scheme as service providers. This would 
increase patients’ access to medicines and reduce cost of accessing medicines 
at CPs. 
8. Further in-depth qualitative studies be conducted to examine reasons behind 
poor patient recollection dosage, pharmacist absenteeism, poor labelling 
practices, and poor generic prescribing 
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APPENDICES 
Appendix 1: Optimal levels of Indicators 
The table below shows reference values of WHO medicine use indicators from seven 
publications. 
Indicators Publications 
Prescribing 
Indicators 
Isah et 
al 
(2002) 
WHO 
(2006) 
Dong et 
al. 
(2011) 
Akl et 
al. 
(2014) 
Ofori 
Asenso 
et al 
(2016) 
El Mahali 
et al 
(2012)  
Bilal 
(2016) 
Average No of 
medicines prescribed 1.6-1.8 <2 
 
≤3 <2   1.6-1.8 
% of medicines 
prescribed by generic 
name 100 100 100 100 100   100 
% encounters/patients 
with antibiotic 
prescribed 
20.0-
26.8 <30 <30 ≤30 <30   20.0-26.8 
% encounters/patients 
with injections 
prescribed 
13.4-
24.1 <20 <10 ≤10 <20   13.4-24.1 
% of medicines 
prescribed from 
essential medicine list 
or formulary 100 100 100 100 100   100 
             
Patient Care 
Indicators 
   
        
Average dispensing 
time (sec) 
   
≥60   ≥60 >180 
% medicines actually 
dispensed 
  
100 
 
100   100 100 
% medicines 
adequately labelled 
  
 
100 
 
100   100 100 
% patients with correct 
knowledge of dosage 
   
100   100 100 
             
Facility Specific 
Indicators 
   
        
Availability of Copy 
of Essential medicines 
list or formulary 
   
100   100   
Availability of Key 
medicines 
  
100 
 
100   100   
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Appendix 2: Volta Region community pharmacies distribution and sampling 
 
No District Total number of 
community 
pharmacies 
Number of sampled 
community 
pharmacies 
1 Ho 11 6 
2 Hohoe 5 3 
3 Ketu South 4 2 
4 North Tongu 3 1 
5 Kpando  2 1 
6 Nkwanta South 2 1 
7 Akatsi South 1  
 
4 
8 South Tongu 1 
9 Krachi East 1 
10 Jasikan 1 
11 Kadjebi 1 
12 Ketu North 1 
13 Keta 1 
TOTAL 34 18 
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Appendix 3: Tool 1: Prescribing Indicator Form and Definitions 
 
Tool 1: Prescribing Indicator Form 
PRESCRIBING INDICATOR FORM 
Community Pharmacy Code: …………………             
Location (Town & District): ………………………… 
Name or Code of Investigator: …………………..                          Date: 
……………………            
No Date of 
Rx 
Age 
(years
) 
Gender 
M/F 
# of 
medicin
es 
prescribe
d 
# of 
generics 
prescribed 
Antibiotic 
(0/1)* 
Injections 
(0/1) * 
# of 
medicin
es on 
EML 
1         
2         
3         
4         
5         
6         
7         
8         
9         
10         
11         
12 
Incr
ease 
whe
n 
need
ed 
        
Tot
al 
        
Ave
rage 
        
Percentage                % 
of generics 
prescribed 
                 
% of 
Patients 
prescribed 
antibiotics 
             % 
Patients 
prescribed 
injections 
      % of 
EML 
medicin
es 
prescribe
d 
  
  
 *0=No 1= Yes 
Adapted from WHO (1993) –How to investigate drug use in health facilities 
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CRITERIA AND DEFINITIONS FOR PRESCRIBING INDICATOR FORM 
 
These are based on definitions used in WHOs manual on how to investigate drug use 
in health facilities. 
Average number of medicines per prescription:  This will measure the degree of 
polypharmacy. 
Formula: AM (average number of medicines) = Total number of medicines 
prescribed (TM) / Total number of patients encountered  
 
Percentage of medicines prescribed by generic name:   
Formula: Percentage of generic named medicines prescribed (PGN) = Total number 
of generic medicines prescribed / Total number of medicines prescribed X 100 
 
Percentage of patients with an antibiotic prescribed: 
Formula: Total number of patients who were prescribed at least an antibiotic (TA)/ 
Total number of patients x 100 
 
Percentage of patients with an injection prescribed: 
Formula: Total number of patients who were prescribed at least an injection (TI)/ 
Total number of patients x 100 
 
Percentage of medicines prescribed from essential medicines list or formulary 
Formula: Total number of EML medicines prescribed (TEML) / Total number of 
medicines prescribed (TM) x 100 
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DEFINITION OF ANTIBIOTICS, AND INJECTIONS  
Antibiotics 
Medicines counted as antibiotic count were based on an adaptation of a recommended 
list in the WHO (1993) manual on how to measure drug use indicators.  
No WHO EML Medicine Code Class 
1 6.2.1 Beta Lactamase antibacterial 
2 6.2.2 Other antibacterial medicines 
3  Antibacterial topical medicines 
4 21.1 Anti-infective  Ophthalmic medicines 
(excluding acyclovir) 
5  Other antibacterial medicines for the ear 
infections such as Neomycin and Polymyxin 
B. 
Classifications were based on WHO (2017b)-WHO Model List of Essential 
Medicines, 20th Edition. Group 5 were not classified in the WHO EML list, thus why 
no code was assigned to it. 
 
Injections 
Medicine formulations that are administered through the use of syringes and needles 
were determined to be injections. For the purposes of the study hormones, vaccines 
and contraceptives that were administered by use of syringes and needles were not 
counted as injections. 
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Appendix 4: Tool 2: Patient/Caregiver Care Form and Definitions 
 
Tool 2: Patient/Caregiver Care Form 
PATIENT /CAREGIVER FORM 
Community Pharmacy Code: …………………             
Location (Town & District): ………………………… 
Name or Code of Investigator: …………………..                 Date: 
……………………            
No Patient/Car
egiver 
Identifier (if 
needed) 
Dispensin
g time 
(secs) 
# 
med
icine
s 
presc
ribed 
#  
medici
nes 
dispens
ed 
# 
medici
nes 
adequa
tely 
labelled 
Patients 
knowled
ge of 
dosage 
(0/1) * 
Pharma
cist 
present 
(0/1) 
Dispens
ing by 
Pharma
cist 
(0/1) 
Categ
ory of 
Dispe
nser 
1          
2          
3          
4          
5          
6          
7          
8          
9          
Increase rows 
when needed 
Count 
        
Tot
al 
         
Av
era
ge 
         
Percentage               
% of 
medicin
es 
dispense
d 
                 
% of 
medici
nes 
adequat
ely 
labelled 
             
% of 
patients 
with 
correct 
knowled
ge of 
dosage 
   
    
    
 *0=No 1= Yes 
Adapted from WHO (1993) –How to investigate drug use in health facilities 
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PATIENT/ CAREGIVER EXIT SURVEY QUESTIONNAIRE 
Community Pharmacy Code: ………………  
Patient/Caregiver No/Code: ………………..                                                             Date:  
1. Are you a CAREGIVER or PATIENT? 
2. Age (if caregiver)  
 
3. Gender (if caregiver) 0- MALE       1-FEMALE 
 
4. Is Patient a subscriber to a Health Insurance Scheme?  0- YES     1- NO   3-DON’T 
KNOW 
 
5. If Yes what type of Health Insurance Scheme?  0-PUBLIC   1- PRIVATE   2-BOTH 
 
6. Are you filling prescription based on insurance? 0 –YES    1- NO 
7. What type of insurance scheme? 
0- National Health Insurance 
1- Private Health Insurance Scheme 
8. Why prescription was brought to the pharmacy? 
1) Hospital Out of stock   
2) Prefer services of the community pharmacy 
3) Long queues at hospital Pharmacy 
4) Others, Specify ……………………………..   
 
 For those who did not receive all/some medicines on prescription ask this 
9. Why did you not receive all/some medicines on prescription?                              
1) Medicine out of stock 
2) Medicine not affordable 
3) I do not feel the need for the medicine 
4) Already Purchased/Received 
5) Others; Specify ………………………………….. 
10. Medicine Labelling Check list 
# Medicine Patient Name Medicine Name Dosage 
1    
2    
3    
4    
5    
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CRITERIA AND DEFINITIONS FOR PATIENT/CAREGIVER CARE SHEET 
These are based on definitions used in WHOs manual on how to investigate drug use 
in health facilities 
 
Indicators measured here are average dispensing time, percentage of medicines 
actually dispensed, percentage of medicines adequately labelled and patients’ 
knowledge of correct dosage. 
Average dispensing time: Defined as the time (in seconds) between a patient arriving 
at the dispensary counter and leaving. The waiting time is excluded. This is calculated 
by dividing the total time a group of patients spend at the dispensary by the number of 
patients.  
 
Formula: Average dispensing time (S) = R (total dispensing times for Q number of 
patients)/ Q  
 
Percentage of medicines actually dispensed: Defined as a percentage of the total 
number of medicines prescribed for an N number of patients. 
 
Formula: % of medicines actually dispensed (PD) = TD (Total number of medicines 
dispensed to N patients)/Total No of medicines prescribed for N patients x 100 
 
Percentage of medicines adequately labelled:  Adequate labelling is defined as a 
package containing at least information on patient name, medicine name and 
medicine dosage.  
 
Formula:  % of medicines adequately labelled (PL) = Total number of medicines 
dispensed to N patients adequately labelled / Total number of medicines dispensed 
(TD) x 100 
Percentage of Knowledge of correct dosage: Correct dosage is defined as patient 
adequately recall dosage for all medicines dispensed.  
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Formula: % of patients with knowledge of correct dosage (PK) = Total number of 
patients who can correctly recall dosage of all medicines / total number of patients 
questioned x 100 
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Appendix 5: Tool 3: Community Pharmacy Summary Form and Definitions 
 
Tool 3: Community Pharmacy Summary Form 
COMMUNITY PHARMACY SUMMARY FORM 
Community Pharmacy Code: …………………                            Date: 
…………………….. 
Location (Town & District): ………………….. 
Distance to Nearest Health Facility? ....................  Type of Health 
Facility…………………...   
Ownership of Health Facility. Govt.         Private         NGO          Mission           
Others…… 
Is the Community Pharmacy Accredited to a Health Insurance Scheme?  Yes  No 
Type of Health Insurance Scheme       Public                        Private 
How long has community pharmacy been operating from current premises?  
………… 
Essential 
medicines 
List 
Available  
(any) (0/1) 
Current 
EML  
Available 
(0/1) 
Ghana STG 
Available 
(any 
version) 
(0/1) 
Current 
Ghana STG 
Available 
(0/1) 
Any other 
Formulary 
Available 
(0/I) 
Name of 
other 
Formulary 
Available 
      
 
No Key Essential Medicines in Stock In Stock 
(0/I) 
 
1 ACTs (Tabs and Suspensions)   
 
 
 
 
 
Percentage of Key 
Medicines in stock 
 
2 Amoxicillin  
3 Amoxicillin plus Clavulanic acid  
4 Macrolide  
5 Oral rehydration salt  
6 Zinc tablets  
7 Iron containing products  
8 Metformin  
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9 Tetracycline Eye Ointment  ……………………. 
10 Thiazide Diuretics  
11 Mebendazole  
12 Ciprofloxacin  
13 Benzoic Acid Compound Ointment 
(Whitefields) 
 
14 Either, Clotrimazole (1%), Miconazole 
(2%) topical preparations indexed as one 
 
15 Diclofenac Preparations (Oral or 
Suppositories) 
 
 
CRITERIA AND DEFINITIONS FOR COMMUNITY PHARMACY 
SUMMARY FORM 
Percentage of available key medicines: A list of 15 medicines identified on the 
essential medicines list which are recommended for treating common problems will 
be created. 
Formula: 
Percentage of Key medicines available: Number of Key medicines in stock/ Total 
Number of key medicines looked out for x 100. 
List of Key Medicines developed based on top ten cause of OPD attendances and 
death in the Volta Region (Ghana Health Service (GHS), 2014). 
No  Condition Medication 
1 Malaria ACTs (Tabs and Suspensions) 
2 Acute Respiratory Tract Infections Amoxicillin 
3  Amoxicillin plus Clavulanic 
acid 
4  Macrolide 
5 Acute Diarrhoea in Children Oral rehydration salt 
6  Zinc tablets 
7 Anaemia Iron containing products 
8 Diabetes Mellitus Metformin 
9 Acute Eye Infection (Conjunctivitis) Tetracycline Eye Ointment 
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10 Hypertension Thiazide Diuretics 
11 Intestinal Worms Mebendazole 
12 Acute Urinary Tract Infection Ciprofloxacin 
13 Skin Diseases (Fungal) Benzoic Acid Compound 
Ointment (Whitefields) 
14  Either, Clotrimazole (1%), 
Miconazole (1%) topical 
preparations indexed as one 
15 Rheumatism and Joint Pain Diclofenac Preparations (Oral 
or Suppositories) 
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Appendix 6: Participant Information Sheet English (Pharmacy Staff) 
 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
Participant Information Sheet (pharmacy staff) 
 
Dear Participant,  
                            Firstly, I appreciate your willingness to listen to what I have to say 
about this research. My name is Gabriel Essilfie-Essel and I am a Ghanaian 
postgraduate student of the School of Public Health, Faculty of Community and 
Health Sciences, University of Western Cape, South Africa. I am currently working 
on a mini thesis as a requirement for the completion of a MASTER OF PUBLIC 
HEALTH (MPH) degree. The mini thesis is being supervised by Dr. Hazel Bradley. 
If you have any questions you may freely ask now, if I am in your presence or contact 
me by through my contact details found at the end of this document. 
 
TITLE OF RESEARCH 
Quality of care of patients presenting prescriptions at community pharmacies in a 
region of Ghana.  
 
PURPOSE OF RESEARCH 
The purpose is to assess the quality of care of patients presenting prescriptions at 
community pharmacies in a region of Ghana. The results of the research will help 
inform policies aimed at improving the practices in the community pharmacies. Your 
participation is therefore very important for the issues to be found out so we all derive 
benefits from the findings.  
 
WHAT WILL HAPPEN WHEN YOU AGREE TO PARTICIPATE 
If you agree to participate, two major things will happen. The data collector will first 
and foremost observe for availability of some indicators in the pharmacy. After wards 
data collectors will observe you while you attend to patients after which patients will 
be interviewed briefly while the exit your pharmacy. 
 
CONFIDENTIALITY 
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Your confidentiality will be guaranteed. Your name will not be captured on the data 
forms. The informed consent form you will sign will be kept in a locked cupboard 
free from any other person. Data will also be stored on a computer and password 
protected and only accessible to the researcher. After the research is conducted the 
manual data sheets will be destroyed without leaving a trace. If the government or 
any other agency requests for a report of this research, your confidentiality will still 
be protected. 
 
ARE THERE ANY RISKS FOR PARTICIPATING IN THIS RESEARCH? 
All human interactions and talking about self or others carry some amount of risks. 
We will nevertheless minimise such risks and act promptly to assist you if you 
experience any discomfort, psychological or otherwise during the process of your 
participation in this study. Where necessary, an appropriate referral will be made to a 
suitable professional for further assistance or intervention 
 
BENEFITS 
You may not receive direct or immediate benefits by participating in this research. 
The findings of the research will greatly inform pharmacy owners, practitioners and 
policy makers on areas of patient care in community pharmacies which need to be 
improved. In the future any changes to policy and practices from the findings will 
help everyone. It will not cost to you to participate; the only cost will be the time you 
spend talking to us. 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
You have the free will to participate or withdraw from the research at any point after 
agreeing to participate. No penalties will be imposed on you for declining or 
withdrawing. Neither will it mean you will be ruled out form being selected for any 
research conducted by us in the future. 
 
INFORMED CONSENT 
You are required to sign an informed consent form before participating in the study. 
The form is attached to this information sheet for you to read and then take a 
decision. 
 
QUESTIONS 
 
If you have any questions about the research study itself, please contact me Gabriel 
Essilfie-Essel at H/No 60A Mawuli Estates, Ho and on Telephone number 
:0244415147. Email: gabrielessel@gmail.com 
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Should you have any questions regarding this study and your rights as a research 
participant or if you wish to report any problems you have experienced related to the 
study, please contact:  
 
Prof Helen Schneider 
School of Public Health  
Head of Department 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
soph-comm@uwc.ac.za     
 
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za 
 
This research has been approved by the University of the Western Cape’s Research Ethics Committee. 
(REFERENCE NUMBER: BM/16/5/29) 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University Of the Western Cape 
Private Bag X17 
Bellville 7535 
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Appendix 7: Participant Information Sheet English (Patient/Caregiver) 
 
 
UNIVERSITY OF THE WESTERN CAPE 
            Private Bag X 17, Bellville 7535, South Africa 
              Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
  
Participant Information Sheet (PATIENT/CAREGIVER) 
 
Dear Participant,  
                            Firstly, I appreciate your willingness to listen to what I have to say 
about this research. My name is Gabriel Essilfie-Essel and I am a Ghanaian 
postgraduate student of the School of Public Health, Faculty of Community and 
Health Sciences, University of Western Cape, South Africa. I am currently working 
on a mini thesis as a requirement for the completion of MASTER OF PUBLIC 
HEALTH (MPH) degree. The mini thesis is being supervised by Dr. Hazel Bradley. 
If you have any questions you may freely ask now, if I am in your presence or contact 
me by through my contact details found at the end of this document. 
 
TITLE OF RESEARCH 
Quality of care of patients presenting prescriptions at community pharmacies in a 
region of Ghana.  
 
PURPOSE OF RESEARCH 
The purpose is to assess the quality of care of patients presenting prescriptions at 
community pharmacies in a region of Ghana. The results of the research will help 
inform policies aimed at improving the practices in the community pharmacies. Your 
participation is therefore very important for the issues to be found out so we all derive 
benefits from the findings.  
 
WHAT WILL HAPPEN WHEN YOU AGREE TO PARTICIPATE 
If you agree to participate, two major things will happen. The data collector will 
observe from afar while you are being attended to at the pharmacy. Afterwards the 
data collector will ask you a few questions on your way out.  The time you will spend 
will actually depend on how long you spend at the pharmacy. The data collector will 
not spend more than 15 minutes asking you questions after you have been attended to 
at the pharmacy. 
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CONFIDENTIALITY 
Your confidentiality will be guaranteed. You will be identified by a code which will 
be linked to the data sets gathered from surveying you but not your name.  The data 
collector will not ask you for your name. The informed consent form you will sign or 
thumbprint will be kept in a locked cupboard free from any other person. Data will 
also be stored on a computer and password protected and only accessible to the 
researcher. After the research is conducted the manual data sheets will be destroyed 
without leaving a trace. If the government or any other agency requests for a report of 
this research, your confidentiality will still be protected. 
 
ARE THERE ANY RISKS FOR PARTICIPATING IN THIS RESEARCH? 
All human interactions and talking about self or others carry some amount of risks. 
We will nevertheless minimise such risks and act promptly to assist you if you 
experience any discomfort, psychological or otherwise during the process of your 
participation in this study. Where necessary, an appropriate referral will be made to a 
suitable professional for further assistance or intervention 
 
BENEFITS 
You may not receive direct or immediate benefits by participating in this research. 
The findings of the research will greatly inform pharmacy owners, practitioners and 
policy makers on areas of patient care in community pharmacies which need to be 
improved. In the future any changes to policy and practices from the findings will 
help everyone. It will not cost to you to participate; the only cost will be the time you 
spend talking to us. 
 
VOLUNTARY PARTICIPATION AND WITHDRAWAL 
You have the free will to participate or withdraw from the research at any point after 
agreeing to participate. No penalties will be imposed on you for declining or 
withdrawing. Neither will it mean you will be ruled out form being selected for any 
research conducted by us in the future. 
 
INFORMED CONSENT 
You are required to sign an informed consent form before participating in the study. 
The form is attached to this information sheet for you to read and then take a 
decision. 
 
QUESTIONS 
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If you have any questions about the research study itself, please contact me Gabriel 
Essilfie-Essel at H/No 60A Mawuli Estates, Ho and on Telephone number 
:0244415147. Email: gabrielessel@gmail.com 
 
Should you have any questions regarding this study and your rights as a research 
participant or if you wish to report any problems you have experienced related to the 
study, please contact:  
 
Prof Helen Schneider 
School of Public Health  
Head of Department 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
soph-comm@uwc.ac.za     
 
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za 
 
This research has been approved by the University of the Western Cape’s Research Ethics Committee. 
(REFERENCE NUMBER: BM/16/5/29) 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University Of the Western Cape 
Private Bag X17 
Bellville 7535 
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Appendix 8: Participant Information Sheet in Ewe  
 
 
UNIVERSITY OF THE WESTERN CAPE 
     Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
 
DODOGBALE NA @$N$ KPLE @$N$DZIKP$LA 
NYE%E KPEDE~UT$ L_L_A, 
 
 X4 nye5e akpedada be adotom ase nusiwo magbl4 tso nug4mekuku 
ya `u. ~knye enye Gabriel Essilfie-Essel eye menye Ghanavi dzidzi si le 
School of Public Health, Faculty of Community and Health Sciences, 
University of Western Cape, le South Africa. Ne mewu 24 ya nu dedie 
la, woanam dzesigbale abe MASTER OF PUBLIC HEALTH (MPH). Dr. 
Hazel Bradley ele 24 ya dzi kp4. M42e2e le be abia biabia desiadem fifila 
aloo ate `u ado biabia la dam to nye5e ga5om4 2zesi ya l1 agbale la 5e 
nuwuwu. 
 
NUG$MEKUKU LA %E TANYA: 
Dzikp4kp4 nyuiet4 na 24n4wo le duwofe atikex45e le Ghana 5e nuto 
adem1. 
 
NUG$MEKUKU LA %E TADODZINU 
Dodo nyuit4 na 24n4wo le dusuewo 5e atik1na 5e le Ghana 5e nuto dem1 
enye tadodzinu na nug4me kuku sia. 
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E5e nutsome nuwo akpede dodo w4la wo `u hena af4dede nyuit4 na 
24n4wo le mia5e atikex45ewo. Eyata w9 5e kpekpede`u le nug4mekuku 
ya me hia vevie `ut4 be miakata miahp4 dzidzeme. 
 
NUKA ATSO WO%E KPEKPEDE~U YA ME? 
Ne el- de dzi la, nu eve le dz4dz4 ge. Nug4mekula an4 a2z4ge ale `ku de 
`uwo le esime eyi de atikex4 la. Le ema megbe a, nug4mekula abia 
biabia de wo. ^eyiyi gbegble a deke man4 me o, elabena aza abe ga5o5o 
wi at- p1 le biabia kple `udodoa `u le esime adogo tso atik1x4fe la. 
 
KAKADEDZI BE ~K$WO MADZE LE DODO SIA ME O 
~k4wo madze le dodo ya 5e akpa deke o, ke bo` dzesi a deko an4 wo5e 
`udodo a wo`u. Medze be na y4 `k4 wo na nug4mekula o. woatu agbale 
site na d1 asi la de adaka de me eye wo5e `udodo wo ha an4 computer si 
an4 nug4mekula la dede gb4. Le nugumekuku la 5e megbe la, w9atu dzo 
agbale sia agbale si w9za le 24w4w4 la me eye woan4 Computer la dzi 
ko. Ne ohia be dzidudu aloo 24w4 5ea de ahia nutsotso atso d4w4w4 la 
me la, `k4 wo madze le afima ha o. 
 
KUXI KA AN$ ANYI LE WO%E KPEKPEDE~U NANA LA ME? 
Kuxi wo n4na amegbet4 5e d4w4w4 sia `u, gake mina wo kakadedzi be 
ni mia na nuv4 a deke adz4 de wo5e kpekpede`u nana me o. 
Ne w9ahia be miaw4 d4d4do de le d4 sia me la, miadi d4w4la adodoe wo 
be wo7kpe de mia`u. 
 
VIDE KA LE NYE %E KPEKPEDE~U NANA LA ME? 
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Numetsonu sia ado le nug4mekuku ya me akpe de atik1na5e d4w4lawo, 
dzidudu kple d4w45e bubua wo `u ale be wo7w4 dodo nyuit4wo na vide 
ame gede ts4 kpede wo `ut4 `u. 
Ke efia be w95e 6eyiyi si neza la tr4 zu vide na ame gede. 
 
L$L$NU FAA D$W$W$ KPLE GBEGBE 
M4dede le be na kpede mia`u le mia5e nug4mekuku sia me alo agbe be 
makpede mia`u o. Amedeke makp4 m4 ahe nya deke de `uwo le w95e 
gbegbe ta o. M4 le be go bubu me la, miate `u ay4 wo na kpekpde `u 
6eyiyi bu me faa. 
 
L$L$DEDZI 
Ehia be n’ade asi agbale te be el- be kpekpede`u le d4w4w4sia me. 
L4l4dedzi agbale sia la kpede dodo gbale ya `u.  
 
BIABIAWO 
Ne biabia dewo le asiwo ku de d4 si ne w4 la `u la, dim le dzesi siawo 
dzi: 
Gabriel Essilfie-Essel le H/No 60A Mawuli Estates, Ho 5o ka nam le: 
0244415147. Email: gabrielessel@gmail.com 
 
 
Nenye be ku6i ade le numetsotso sia `ua, yor kafodzesi siawo: 
 
Prof Helen Schneider 
School of Public Health  
Head of Department 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
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soph-comm@uwc.ac.za     
 
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za 
 
This research has been approved by the University of the Western Cape’s Research 
Ethics Committee. (REFERENCE NUMBER: BM/16/5/29) 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University Of the Western Cape 
Private Bag X17 
Bellville 7535 
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Appendix 9: Participant Information Sheet in Akan (Twi)  
 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
 
$NEA $KA ADESUA DWUMADIE YI HO NS!M ( 
$YAREFO/AYAREFO$ HW!FO ) 
$d4fo4 a woka dwumadie yi ho, nea edikan, mew4 ahomeka s1 wagye 
atum s1 wobetie w4 aso pa mu nea mereka afa nhwehwem yi ho. Medin 
de Gabriel Essilfie Essel a mey1 Ghana ni; na merek4 sukum anaa 
osuani w4 School of Public Health, Faculty of Community and Health 
Sciences, University of Western Cape, South Africa. Na mmom 
mprenpren yi merey1 nhwehw1m akyer1kyer1 mens4 hw1 a ebetwa to4 
ho akade1 ma manya MASTER OF PUBLIC HEALTH (MPH) abodin. 
Dr. Hazel Bradley na 4retene tene me fa madesua no ho. S1 wow4 
ns1mmisa anaa as1misa bi a wow4 ho kwan s1 wob1y1. Wobebisa 
mankasa ana afa makyikwan ab11fo kwan so a y’antitim w4 ns1m yi 
awiei p11. 
NHWEHWEM DWMADIE NO TIBAN 
Enti ayarefo4 a wo kura nkrataa k4gye nnuru w4 br4fu nnuru afrafra k4 
yiye anaa? 
D!N NE NHWEHWEM NO BOTAE 
Botae ne s1 wobehw1 na ayarefo4 a wokurakura nkrataa benya nnuru 
pa afiri adwuma a w4frafra bor4fo nnuru no h4 na wanya ayaresa papa; 
na nea ebefiri nhyehye1i no mu aba ma 1ret4 sin no, watumi de nne1ma 
pa agu akwan mu ay3 no yiye; na nea 1y1 no nso, wohy1 mu kena. 
S! WOGYE TUMI S! WODE WOHO B!HY! DWUMADIE NO MU A, 
D!N NA !B!BA 
Nne1ma ahorow mienu na ebehia. Nea w4hw1 yae no b1hw1 nne1ma mu 
afiri akyiri wo bere ko a obi regye n’ayaresa no afiri bor4fo nnuru 
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afrafafo no h4. !no akyi no nea w’ahu afa ho no nyinaa, abebisa wo 
ns1m bi afa ho. Bere a wobes1e w4 h4 no b1kyere bere a wos1ei w4 
nnuru afrafra no h4. Na mom 4rens1e bere bebree a 1b1bro sima dunum. 
Y!MMFA WO HO NS!M BIARA NNTO BAHA 
Wo ho ns1m biara 1renk4 ab4nten mma obi nte anaa nnhunu na mom 
y1b1ma wo ahy1nsode1 bi wonkotoo na wunim. $nea 4gye wo ho ns1m no 
mpo 1remmisa wodin. Na 4nea 4hwehw1 wo ho ns1m no nkuto na 
obentimtim n’ensa ns1nkyer1ni na wak4tum ahy1 beae1 bi obi 
1rennhunu agyes1 4nea 4y1 nhwehwem no nkutoo na onim. !no akyi nso 
no, wode beguab11fo mfidie so de as1m bi ato so a wonkutoo na wonim. 
Ak4y1 s1 kradua safoa, wunkutoo na wubetumi abue. W4y1 nhwehwem 
no nso wie a nea w4de agu nkrataa so no nyinaa, w4b1s1e no. S1 mpo 
aban anaa adwumakuo bi bisaa anaa hwehw1 a, w4rennya. Wo ho banb4 
ay1 krado. 
EHU ANAA OSURO BI W$ OBI A OP! S! $DE NEHO HYE SAA 
NHWENHWE YI MU ANAA? 
Obiabiara a 4ne obi bedi wu4 ankasa ho nk4m4 anaa obi forforo bi ho 
nk4mm4 no, ehu anaa osuro kakra w4 mu. Nanso 4kwan biara so no 
wobeyi saa hu afri h4 na wadi wakyi pintin w4 osuo mu o anaa owia mu 
o; s1 biribi akyekyere anaa ahy1 wo so. S1 ebehia mpo s1 y1de b1hy1 obi 
foforo nsa ma wabua wo afiri saa haw no mu a, y1b1y1. 
MFASODE ANAA ABADE! B!N NA !W$ MU 
Ebia w4rennya mfaso4 anim anim yi ara nanso mpanin s1 wa bom na 
1kyer1 w’ad4; ebia na daakye nne1ma ak4 yiye ma obiara aserew. 
WANKWASA WODE WOHO BEHYE MU A OBIBIARA NHY! WO SO 
ANAA WOBEFIRI MU W$ WAKOMA MU 
S1 wonya gye tum s1 wobehy1m mu a, saa ara na wobetumi afiri 
aberebiara wop1 mu a akwanside1 biara nni ho. 
$KWANB!N NA OBI A WAGYE ATUM NO BEHU NOGYINABEA? 
W4de ho krata b1tare yi ho ma wankasa wakenkan ahunu mu ns1, ate 
ase ansa na wode wonsa ahy1 ase. 
NS!MMISA 
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S1 wow4 ns1mmisa bi a, makyi kwan ne Gabriel Essilfie Essel, H/No 
60A Mawuli Estates, Ho. Anaa fr1 m3 w4 0244415147 anaa makyiri kwan 
w4 ab11fo kwan so ne Email gabrielessel@gmail.com. 
Wo be tumi abisa mmpanin fo yi so ns1m 
Prof Helen Schneider 
School of Public Health  
Head of Department 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
soph-comm@uwc.ac.za     
 
 
Prof José Frantz  
Dean of the Faculty of Community and Health Sciences  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za 
 
This research has been approved by the University of the Western Cape’s Research 
Ethics Committee. (REFERENCE NUMBER: BM/16/5/29) 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University Of the Western Cape 
Private Bag X17 
Bellville 7535 
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Appendix 10: Consent Form-English (Pharmacy Staff/ Patient/Caregiver) 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
 
CONSENT FORM 
Title of Research Project:  Quality of care of patients presenting prescriptions at 
community pharmacies in a region of Ghana  
 
The study has been described to me in language that I understand. My questions 
about the study have been answered. I understand what my participation will involve 
and I agree to participate of my own choice and free will.  I understand that my 
identity will not be disclosed to anyone. I understand that I may withdraw from the 
study at any time without giving a reason and without fear of negative consequences 
or loss of benefits.    
 
Participant’s name _______________________ 
Participant’s signature ________________________           
Date________________________ 
 
 
Name of Researcher/person taking the CONSENT________________________
     
Signature of Researcher /person taking the CONSENT 
__________________________ 
 
Date ___________________________    
                 Day/month/year 
 
A copy of this CONSENT form has been provided to the participant. 
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Appendix 11: Consent Form-Ewe (Patient/Caregiver) 
 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
 
L_L_DEDZI %E AGB&LE 
Nug4mekuku 5e Tanya: Dzikp4kp4 nyuiet4 na d4n4wo le duwo 5e 
atik1x4fee le   Ghana 5e nuto adem1. 
 
Wod1 dodo ya 64m1 nam le nye `ut4 5e d1gb1 m1 eye wodo nye5e biabia 
wo k7t7 `u nam. Menya nye 5e d4lasi eye m8l4 tso dzim1 faa be 
makpede dodo ya `u. Mese eg4me xa be `k4nye madze le dodo ya fe 
afisiafio eye m4dede le be mate `u ade dokuinye le dodo ya me 6esia6i 
v-v- ma n4 me. 
 
~k4nye:_________________________________ 
Nye5e dzesi:___________________________________ 
Egbe 5e nk1k1:____________________________________ 
Nug4mekula 5e `k4:__________________________________ 
Nug4mekula 5e dzesi:___________________________________ 
Egbe 5e nk1k1:_________________________________________ 
L_L_DEDZI 5e agb7le sia ha an4 kpede`ut4 la asi 
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Appendix 12: Consent Form- Akan (Twi) (Patient/ Caregiver) 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 21-959 2809, Fax: 27 21-959 2872 
E-mail: soph-comm@uwc.ac.za 
 
AGYE ATUM KRATAA 
Nhwehwem Dwumadie No Tiban: Hw1pa a 1s1 s1 br4fo nnuru afrafrafo 
w4 4man yi mu de hw1 ayarefo4 k4 yiye anaa? 
Wayi adesua no mu ns1m nyinaa akyer1 me w4 mankasa mekasa a 
meka mu ma mate ase1 s1 mede meho b1hy1 mu a obi nnhy1 me so. 
Manya meho ntiase1 nso s1 obibiara 1rentumi nnyi menipasu nkyer1 
obi. Na mansan manya meho ntiase1 s1 aberebiara a m1ye madwene s1 
m1gyae anaa mefri adesua no mu no, mek4 a mere mma nkyerekyere 
mu biara a mere mma hu nea 1besi m’akwan mu biara; s1 mpo 
mehwere mfaso4 a menya afiri mua; 1ny1 hwee. 
 
NEA $HY! ADESUA NO MU BI 
DIN………………………………………………….. 
NEA $HY! ADESUA NO MU DIN NSAANO NSENKYER! 
NE…………………………………………………………………………………… 
DA NO……………………………………………………………… 
 
$NEA $Y! NHWEHWEM NO 
DIN……………………………………………………. 
N’ENSA ANO DIN 
NSENKYER!NE………………………………………………….. 
DA NO……………………………………………………………………………… 
                                            DA/BOSOM/AFE 
W4de saa krataa yi baako a wayi no saa p1p11p1 ama 4desuafo yi. 
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Appendix 13: UWC BMREC Approval Letter 
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Appendix 14: Permission Letter for Pharmacy Management 
 
The Manager 
…………………………… 
Date: 
 
Dear Sir/Madam 
 
REQUEST FOR PERMISSION TO CONDUCT RESEARCH 
 
I am a registered Master’s student in the School of Public Health, University of the 
Western Cape, Cape-Town, South Africa. My supervisor is Dr. Hazel Bradley. 
 
The proposed topic of my research is to assess the quality of care of patients 
presenting prescriptions at community pharmacies in the Volta region of Ghana. 
   
I am hereby seeking your consent to conduct this research at your facility. To assist 
you in reaching a decision, I have attached to this letter a copy of participation 
information sheet. You will also be required to sign a consent form (attached). 
 
Upon completion of the study, I undertake to provide you with a bound copy of the 
mini-thesis. 
Should you require any further information, please do not hesitate to contact me or 
my supervisor through the contact details available on the information sheet. 
 
Your permission to conduct this study will be greatly appreciated. 
 
Yours sincerely, 
 
……………………………………. 
 
Gabriel Essilfie-Essel 
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